Blue Sphere (BLSP) S-1 15 Aug 16 IPO registration Financial data

Document and Entity Information

Document and Entity Information	6 Months Ended
	Jun. 30, 2016
Document And Entity Information
Entity Registrant Name	BLUE SPHERE CORP.
Entity Central Index Key	1,419,582
Document Type	S1
Trading Symbol	BLSP
Document Period End Date	Jun. 30, 2016
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity a Well-known Seasoned Issuer	No
Entity a Voluntary Filer	No
Entity's Reporting Status Current	Yes
Entity Filer Category	Smaller Reporting Company

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015	Sep. 30, 2015	Sep. 30, 2014
CURRENT ASSETS:
Cash and cash equivalents	$ 1,280	$ 2,732	$ 161	$ 298
Trade accounts receivable	861	1,434
Other current assets	525	508	21	265
Total current assets	2,666	4,674	182	563
PROPERTY, PLANT AND EQUIPMENT, net of accumulated depreciation	17,938	18,139	31
OTHER LONG TERM ASSETS	6,137	5,920
INVESTMENTS IN JOINT VENTURES	8,927	7,434	4,952	469
INTANGIBLE ASSETS	3,967	3,930
Total assets	39,635	40,097	5,165	1,032
CURRENT LIABILITIES:
Current maturities of long term loan	1,711	1,763	32	32
Accounts payables	3,475	1,144	58	12
Other accounts payable and liabilities	1,443	2,679	681	343
Debentures, notes and loans	84	7,363	519	231
Deferred revenues from joint ventures	10,409	8,916	6,434
Total current liabilities	17,122	21,865	7,724	618
LONG TERM BANK LOANS	18,888	19,016	135	104
LONG TERM LOANS AND LIABILITIES	6,855
DEBENTURES	2,410	2,361
WARRANTS TO ISSUE SHARES	2,647	544
STOCKHOLDERS' DEFICIENCY:
Common shares of $0.001 par value each: Authorized: 1,750,000,000 shares at June 30, 2016 and September 30, 2015. Issued and outstanding: 243,051,884 shares and 167,952,595 shares at June 30, 2016 and September 30, 2015, respectively	1,318	1,256	1,244	1,126
Proceeds on account of shares		20	20	20
Treasury shares	(28)	(28)	(28)
Accumulated other comprehensive loss	46
Additional paid-in capital	42,293	39,764	39,474	35,106
Accumulated deficit	(51,916)	(44,701)	(43,404)	(35,942)
Total Stockholders' Deficiency	(8,287)	(3,689)	(2,694)	310
Total liabilities and Stockholders' Deficiency	$ 39,635	$ 40,097	$ 5,165	$ 1,032

CONDENSED CONSOLIDATED BALANCE3

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares	Jun. 30, 2016	Dec. 31, 2015	Sep. 30, 2015	Sep. 30, 2014
Condensed Consolidated Balance Sheets
Common shares, par value (in dollars per share)	$ 0.001	$ 0.001	$ 0.001	$ 0.001
Common shares, shares authorized	1,750,000,000	1,750,000,000	1,750,000,000	1,750,000,000
Common shares, shares issued	243,051,884	180,502,443	167,952,595	50,109,036
Common shares, shares outstanding	243,051,884	180,502,443	167,952,595	50,109,036

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2016	Dec. 31, 2015	Jun. 30, 2015	Dec. 31, 2014	Jun. 30, 2016	Jun. 30, 2015	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Condensed Consolidated Statements Of Operations
REVENUES	$ 1,303	$ 400			$ 2,706
COST OF REVENUES	(1,007)	(360)			(2,323)
GROSS INCOME	296	40			383
OPERATING EXPENSES -
General and administrative expenses	2,809	1,005	$ 2,439	$ 827	4,590	$ 3,450	$ 5,331	$ 7,120	$ 1,831
Other income (losses)			(38)	19	(102)	(57)	(14)		20
OPERATING LOSS	2,513	965	2,401	846	4,105	3,393
FINANCIAL EXPENSES, net	1,131	332	732	468	3,110	1,551	2,145	256	119
NET LOSS FOR THE PERIOD	$ 3,644	$ 1,297	$ 3,133	$ 1,314	$ 7,215	$ 4,944	$ 7,462	$ 7,376	$ 1,970
Net loss per common share - basic and diluted (in dollars per share)	$ (0.017)	$ (0.007)	$ (0.04)	$ (0.026)	$ (0.035)	$ (0.068)	$ (0.088)	$ (0.334)	$ (0.345)
Weighted average number of common shares outstanding during the period - basic and diluted (in shares)	225,772,114	177,155,607	79,543,760	51,031,823	210,663,024	72,482,628	85,135,631	22,077,519	5,705,471

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2016
Income Statement [Abstract]
NET LOSS	$ 3,644	$ 7,215
Other comprehensive loss, net of tax:
Currency translation adjustments	(26)	(46)
TOTAL COMPREHENSIVE LOSS	$ 3,618	$ 7,169

STATEMENTS OF CHANGES IN SHAREH

STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT (Unaudited) - USD ($)	Common Stock, $0.001 Par Value [Member]	Proceeds on account of shares [Member]	Treasury Shares [Member]	Accumulated other comprehensive income [Member]	Additional paid-in Capital [Member]	Accumulated deficit [Member]	Total
Balance at beginning at Sep. 30, 2012	$ 184,000				$ 25,744,000	$ (26,596,000)	$ (668,000)
Balance at beginning (shares) at Sep. 30, 2012	1,634,478
Share based compensation					203,000		203,000
Issuance of common stock, net of issuance costs	$ 406,000				485,000		891,000
Issuance of common stock, net of issuance costs (shares)	3,593,579
Issuance of shares for services	$ 207,000				551,000		758,000
Issuance of shares for services (shares)	1,834,929
Issuance of common stock in respect of issuance of convertible notes	$ 289,000				15,000		304,000
Issuance of common stock in respect of issuance of convertible notes (shares)	2,558,224
Net loss for the period						(1,970,000)	(1,970,000)
Balance at ending at Sep. 30, 2013	$ 1,086,000				26,998,000	(28,566,000)	(482,000)
Balance at ending (shares) at Sep. 30, 2013	9,621,210
Share based compensation					1,711,000		1,711,000
Issuance of common stock, net of issuance costs	$ 9,000				891,000		900,000
Issuance of common stock, net of issuance costs (shares)	9,054,967
Issuance of shares for services	$ 17,000				3,203,000		3,220,000
Issuance of shares for services (shares)	17,486,132
Issuance of common stock in respect of issuance of convertible notes	$ 14,000				1,262,000		1,276,000
Issuance of common stock in respect of issuance of convertible notes (shares)	13,946,727
Issuance of convertible debentures containing a beneficial conversion feature					1,041,000		1,041,000
Proceeds on account of shares		$ 20,000					20,000
Net loss for the period						(7,376,000)	(7,376,000)
Balance at ending at Sep. 30, 2014	$ 1,126,000	20,000			35,106,000	(35,942,000)	$ 310,000
Balance at ending (shares) at Sep. 30, 2014	50,109,036						50,109,036
Share based compensation					97,000		$ 97,000
Issuance of shares for services	$ 1,000				93,000		94,000
Issuance of shares for services (shares)	544,041
Issuance of common stock in respect of issuance of convertible notes					44,000		44,000
Issuance of common stock in respect of issuance of convertible notes (shares)	471,967
Issuance of convertible debentures containing a beneficial conversion feature					322,000		322,000
Net loss for the period						(1,314,000)	(1,314,000)
Balance at ending at Dec. 31, 2014	$ 1,127,000	20,000			35,662,000	(37,256,000)	(447,000)
Balance at ending (shares) at Dec. 31, 2014	51,125,044
Balance at beginning at Sep. 30, 2014	$ 1,126,000	20,000			35,106,000	(35,942,000)	$ 310,000
Balance at beginning (shares) at Sep. 30, 2014	50,109,036						50,109,036
Share based compensation					401,000		$ 401,000
Issuance of common stock, net of issuance costs	$ 9,000				338,000		347,000
Issuance of common stock, net of issuance costs (shares)	9,338,682
Issuance of shares for services	$ 33,000				1,541,000		1,574,000
Issuance of shares for services (shares)	33,116,550
Issuance of common stock in respect of issuance of convertible notes	$ 76,000				1,449,000		1,525,000
Issuance of common stock in respect of issuance of convertible notes (shares)	75,532,381
Issuance of convertible debentures containing a beneficial conversion feature					482,000		482,000
Treasury shares			$ (28,000)				(28,000)
Treasury shares (in shares)	(144,054)
Net loss for the period						(7,462,000)	(7,462,000)
Balance at ending at Sep. 30, 2015	$ 1,244,000	20,000	(28,000)		39,474,000	(43,404,000)	$ (2,694,000)
Balance at ending (shares) at Sep. 30, 2015	167,952,595						167,952,595
Balance at beginning at Dec. 31, 2014	$ 1,127,000	20,000			35,662,000	(37,256,000)	$ (447,000)
Balance at beginning (shares) at Dec. 31, 2014	51,125,044
Share based compensation					158,000		158,000
Issuance of common stock, net of issuance costs	$ 2,000				249,000		251,000
Issuance of common stock, net of issuance costs (shares)	2,169,760
Issuance of shares for services	$ 20,000				1,316,000		1,336,000
Issuance of shares for services (shares)	20,357,035
Issuance of common stock in respect of issuance of convertible notes	$ 40,000				1,196,000		1,236,000
Issuance of common stock in respect of issuance of convertible notes (shares)	39,962,236
Issuance of convertible debentures containing a beneficial conversion feature					181,000		181,000
Comprehensive loss						(4,944,000)	(4,944,000)
Proceeds on account of shares							242,000
Net loss for the period							(4,944,000)
Balance at ending at Jun. 30, 2015	$ 1,189,000	20,000			38,762,000	(42,200,000)	$ (2,229,000)
Balance at ending (shares) at Jun. 30, 2015	113,614,075
Issuance of shares for services (shares)							8,035,000
Balance at ending at Sep. 30, 2015	$ 1,244,000	20,000	(28,000)		39,474,000	(43,404,000)	$ (2,694,000)
Balance at ending (shares) at Sep. 30, 2015	167,952,595						167,952,595
Share based compensation					65,000		$ 65,000
Issuance of common stock, net of issuance costs	$ 10,000				178,000		188,000
Issuance of common stock, net of issuance costs (shares)	10,114,848
Issuance of shares for services	$ 2,000				47,000		49,000
Issuance of shares for services (shares)	2,435,000
Net loss for the period						(1,297,000)	(1,297,000)
Balance at ending at Dec. 31, 2015	$ 1,256,000	20,000	(28,000)		39,764,000	(44,701,000)	$ (3,689,000)
Balance at ending (shares) at Dec. 31, 2015	180,502,443						180,502,443
Extinguish of liability upon shares issuance	$ 7,000				627,000		$ 634,000
Extinguish of liability upon shares issuance (shares)	7,103,467
Issuance of common stock, net of issuance costs	$ 36,000	$ (20,000)			573,000		589,000
Issuance of common stock, net of issuance costs (shares)	37,315,232
Issuance of shares for services	$ 4,000				258,000		262,000
Issuance of shares for services (shares)	3,500,000
Issuance of common stock in respect of issuance of convertible notes	$ 14,000				1,031,000		1,045,000
Issuance of common stock in respect of issuance of convertible notes (shares)	13,930,742
Exercise of warrants	$ 1,000				40,000		41,000
Exercise of warrants (shares)	700,000
Comprehensive loss				$ 46,000		(7,215,000)	(7,169,000)
Proceeds on account of shares							1,752,000
Net loss for the period							(7,215,000)
Balance at ending at Jun. 30, 2016	$ 1,318,000		$ (28,000)	$ 46,000	$ 42,293,000	$ (51,916,000)	$ (8,287,000)
Balance at ending (shares) at Jun. 30, 2016	243,051,884						243,051,884

CONDENSED CONSOLIDATED STATEME7

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Jun. 30, 2016	Jun. 30, 2015	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss for the period	$ (1,297,000)	$ (1,314,000)	$ (7,215,000)	$ (4,944,000)	$ (7,462,000)	$ (7,376,000)	$ (1,970,000)
Adjustments required to reconcile net loss to net cash provided by (used in) operating activities:
Share based compensation expenses	65,000	97,000	369,000	158,000	558,000	1,711,000	203,000
Depreciation	68,000	1,000	749,000	3,000	6,000	3,000	3,000
Amortization of intangible assets			48,000
Equity in losses on nonconsolidated subsidiary		19,000		(19,000)
Expenses in respect of convertible notes and loans	322,000	422,000	899,000	1,421,000	1,949,000	684,000	99,000
Non-cash interest			258,000
Changes in Warrants to issue shares	219,000		960,000
Issuance of shares for services	49,000	94,000	262,000	1,336,000	1,574,000	3,220,000	758,000
Project costs expensed				469,000	469,000
Impairment of nonconsolidated subsidiary investment					(22,000)
Decrease in trade account receivables	893,000		611,000
Decrease (increase) in other current assets	(259,000)	(21,000)	(11,000)	107,000	244,000	39,000	(78,000)
Increase in other long term assets	(2,000)		(76,000)
Decrease in accounts payables	(43,000)	(5,000)	2,313,000	60,000	46,000	20,000	5,000
Increase in other account payables	(152,000)	(3,000)	(1,433,000)	54,000	338,000	(103,000)	(62,000)
Increase in Deferred revenues				1,553,000	1,482,000
Net cash provided by (used in) operating activities	(137,000)	(710,000)	(2,266,000)	198,000	(818,000)	(1,802,000)	(1,042,000)
CASH FLOWS FROM INVESTING ACTIVITIES:
Payments on account of project						(198,000)	(271,000)
Short term investments							(7,000)
Acquisitions of subsidiaries, net of cash acquired (Annex A)	(2,130,000)
Investment in nonconsolidated subsidiary		(24,000)
Purchase of property and equipment		(36,000)	(18,000)	(1,000)	(37,000)
Net cash used in investing activities	(2,130,000)	(60,000)	(18,000)	(1,000)	(37,000)	(198,000)	(278,000)
CASH FLOWS FROM FINANCING ACTIVITIES:
Loan origination fee							(178,000)
Loan received	3,378,000	37,000	50,000	461,000	859,000	764,000	666,000
Proceeds from issuance of debentures and warrants	2,672,000
Payment of loans and convertible debentures	(1,241,000)	(7,000)	(1,022,000)	(963,000)	(1,081,000)	(473,000)	(183,000)
Issuance of shares, net					315,000	900,000	1,039,000
Proceeds from issuance of shares and warrants			1,752,000	242,000		20,000
Proceeds from exercise of warrants			41,000
Proceeds from issuance of convertible debenture		560,000		212,000	625,000	1,041,000
Net cash provided by financing activities	4,809,000	590,000	821,000	(48,000)	718,000	2,252,000	1,344,000
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	2,542,000	(180,000)	(1,463,000)	149,000	(137,000)	252,000	24,000
EFFECT OF CHANGES IN EXCHANGE RATES ON CASH BALANCES IN FOREIGN CURRENCIES	29,000		11,000
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	161,000	298,000	2,732,000	118,000	298,000	46,000	22,000
CASH AND CASH EQUIVALENTS AT END OF PERIOD	2,732,000	$ 118,000	1,280,000	267,000	161,000	298,000	46,000
NON-CASH TRANSACTIONS:
Extinguish of debt upon shares issuance	188,000		411,000
Deferred net equity in joint ventures			1,493,000	$ 118,000
Deferred revenues against joint ventures investments					4,952,000
Cash paid during the period for:
Interest	67,000		$ 360,000		$ 172,000	$ 34,000	$ 48,000
Acquisition of subsidiaries, net of cash acquired :
Working capital, excluding cash and cash equivalents	1,070,000
Property and equipment	(17,738,000)
Long term liabilities	24,485,000
Other long term assets	(5,981,000)
Intangible assets	(3,966,000)
Acquisitions of subsidiaries, net of cash acquired (Annex A)	$ (2,130,000)

BASIS OF PRESENTATION

BASIS OF PRESENTATION	3 Months Ended	6 Months Ended
	Dec. 31, 2015	Jun. 30, 2016
Basis Of Presentation
BASIS OF PRESENTATION	NOTE 1 - BASIS OF PRESENTATION: The accompanying unaudited condensed consolidated financial statements have been prepared on the same basis as the audited annual consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the financial position and results of operations of Blue Sphere Corp. (the “Company”). These condensed consolidated financial statements and notes thereto are unaudited and should be read in conjunction with the Company’s audited financial statements included in its Annual Report on Form 10-K for the year ended September 30, 2015, as filed with the U.S. Securities and Exchange Commission. The results of operations for the three months ended December 31, 2015 are not necessarily indicative of results that could be expected for the entire fiscal year. For the reasons more fully described in the Explanatory Note to this Transition Report, our independent registered public account firm was unable to timely complete its review of the Company’s interim financial statements for the transition period from October 1, 2015 to December 31, 2015.	NOTE 1 – BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements have been prepared on the same basis as the audited annual consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the financial position and results of operations of Blue Sphere Corp. (the “Company”). These condensed consolidated financial statements and notes thereto are unaudited and should be read in conjunction with the Company’s audited financial statements included in its Annual Report on Form 10-K for the year ended September 30, 2015, as filed with the U.S. Securities and Exchange Commission. The results of operations for the three months ended June 30, 2016 are not necessarily indicative of results that could be expected for the entire fiscal year.

GENERAL

GENERAL	3 Months Ended	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2016	Sep. 30, 2015
General
GENERAL	NOTE 2 – GENERAL: Blue Sphere Corp. ("the Company"), together with its wholly-owned subsidiaries, Eastern Sphere Ltd. (“Eastern”), Binosphere Inc (“Binosphere”), Johnstonsphere LLC (“Johnstonsphere”), and Sustainable Energy Ltd. (“SEL”), is focused on project integration in the clean energy production and waste to energy markets. The Company was incorporated in the state of Nevada on July 17, 2007 and was originally in the business of developing and promoting automotive internet sites. On February 17, 2010, the Company conducted a reverse merger, name change and forward split of its common stock, and in March 2010 current management took over operations, at which point the Company changed its business focus to become a project integrator in the clean energy production and waste to energy markets. As of December 31, 2015, Johnstonsphere had not commenced operations. On May 12, 2015 the Company formed Bluesphere Pavia (formerly called Bluesphere Italy S.r.l.). Italy S.r.l, a subsidiary of Eastern in order to acquire certain biogas plants located in Italy (see note 3 below). The Company is currently focusing on (i) 10 projects related to the construction, acquisition or development of biogas facilities and (ii) a recently licensed fast charging battery technology.	NOTE 2 – GENERAL Blue Sphere Corp. (“the Company”), together with its wholly-owned subsidiaries, Eastern Sphere Ltd. (“Eastern”), Binosphere LLC (“Binosphere”), Johnstonsphere LLC (“Johnstonsphere”), and Sustainable Energy Ltd. (“SEL”), is focused on project integration in the clean energy production and waste to energy markets. The Company was incorporated in the state of Nevada on July 17, 2007 and was originally in the business of developing and promoting automotive internet sites. On February 17, 2010, the Company conducted a reverse merger, name change and forward split of its common stock, and in March 2010 current management took over operations, at which point the Company changed its business focus to become a project integrator in the clean energy production and waste to energy markets. As of June 30, 2016, Johnstonsphere had not commenced operations. On May 12, 2015 the Company formed Bluesphere Pavia (formerly called Bluesphere Italy S.r.l.). Italy S.r.l, a subsidiary of Eastern in order to acquire certain biogas plants located in Italy (see note 3 below).	NOTE 1 – GENERAL a. Blue Sphere Corp. (“the Company”), together with its wholly-owned subsidiaries, Eastern Sphere Ltd. (“Eastern”), Binosphere Inc (“Binosphere”), Johnstonsphere LLC (“Johnstonsphere”), and Sustainable Energy Ltd. (“SEL”), is focused on project integration in the clean energy production and waste to energy markets. As of September 30, 2015, Tipping LLC and Charlottesphere LLC, two former subsidiaries of the Company, had been dissolved and Johnstonsphere had not commenced operations. On May 12, 2015 the Company formed Bluesphere Pavia (formerly called Bluesphere Italy S.r.l.), a subsidiary of Eastern in order to acquire certain biogas plants located in Italy (see note 2 below). The Company was incorporated in the state of Nevada on July 17, 2007 and was originally in the business of developing and promoting automotive internet sites. On February 17, 2010, the Company conducted a reverse merger, name change and forward split of its common stock, and in March 2010 current management took over operations, at which point the Company changed its business focus to become a project integrator in the clean energy production and waste to energy markets. On October 2, 2014, the Company, together with certain third parties, established Permanent Energy Ltd (“Permanent Energy”) in Israel. Permanent Energy was focused on Build-Own-Operate projects and project integration in the clean energy production and waste to energy markets, primarily in Israel. The Company held a 50% interest in Permanent Energy. Permanent Energy ceased its operations in February 2015 and is in the process of dissolution. The Company is currently focusing on (i) 10 projects related to the construction, acquisition or development of biogas facilities and (ii) a recently licensed fast charging battery technology. On November 26, 2013, the Company amended and restated its Articles of Incorporation to authorize the issuance of 500,000,000 shares of preferred stock, $0.001 par value, in one or more series and with such rights, preferences and privileges as its Board of Directors may determine and to effect a 1 for 113 reverse stock split of the Company’s outstanding common stock. In addition, the Amended and Restated Articles of Incorporation provide, among other things, for indemnification and limitations to the liability of the Company’s officers and directors. As a result of the reverse stock split, which became effective on December 4, 2013, every 113 shares of the Company’s outstanding common stock prior to the effect of that amendment was combined and reclassified into one share of the Company’s common stock, and the number of outstanding shares of the Company’s common stock was reduced from 1,292,103,309 to 11,434,611 shares. All share, stock option and per share information in these consolidated financial statements have been adjusted to reflect the stock split on a retroactive basis. b. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As of September 30, 2015, the Company had approximately $161 thousand in cash, a negative working capital of approximately $7,542 thousand, a stockholders’ deficiency of approximately $2,694 thousand and an accumulated deficit of approximately $43,404 thousand. Management anticipates their business will require substantial additional investments that have not yet been secured. The Company anticipates that the existing cash will not be sufficient to continue its operations through the next 12 months. Management is continuing in the process of fund raising in the private equity markets as the Company will need to finance future activities and general and administrative expenses. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Company’s ability to continue as a going concern is dependent upon raising capital from financing transactions and revenue from operations. These financial statements do not include any adjustments that may be necessary should the Company be unable to continue as a going concern. The Company’s continuation as a going concern is dependent on its ability to obtain additional financing as may be required and ultimately to attain profitability.

INVESTMENTS IN BLUE SPHERE PAVI

INVESTMENTS IN BLUE SPHERE PAVIA	3 Months Ended	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2016	Sep. 30, 2015
Investments In Blue Sphere Pavia
INVESTMENTS IN BLUE SPHERE PAVIA	NOTE 3 – INVESTMENT IN BLUE SPHERE PAVIA: In September 2014, the Company entered into a letter of intent to acquire Kinexia S.p.A.’s right, interest and title in, to and under four biogas projects in the Vigevano area in Italy. The letter of intent also provides for the purchase of three additional biogas projects in the Emillia-Romagna and Lazio regions upon the same principals set forth in the letter of intent and subject to definitive agreements. On December 14, 2015, and pursuant to a Share Purchase Agreement, dated May 14, 2015 ( the “Share Purchase Agreement”), by and among the Company’s indirect wholly-owned subsidiary, Bluesphere Pavia. (formerly called Bluesphere Italy S.r.l.). (“Bluesphere Pavia”), and Volteo Energie S.p.A., Agriholding S.r.l., and Overland S.r.l. (collectively, the “Sellers”), Bluesphere Pavia completed the acquisitions of one hundred percent (100%) of the share capital of Agricerere S.r.l., Agrielektra S.r.l., Agrisorse S.r.l. and Gefa S.r.l . (each, an “SPV” and collectively, the “SPVs”) from the Sellers. Each SPV owns and operates an anaerobic digestion biogas plant in Italy for the production and sale of electricity to Gestore del Servizi Energetici GSE, S.p.A., a state-owned company, pursuant to a power purchase agreement. Pursuant to the Italy Projects Agreement, the Company also issued a corporate guarantee to the Sellers, whereby the Company will secure the obligations of Bluesphere Pavia under the Italy Projects Agreement. Pursuant to the Share Purchase Agreement, the Company paid an aggregate purchase price of $5,646,628 (€5,200,000) (the “Purchase Price”), subject to certain post-closing adjustments, to acquire the share capital of the SPVs. Fifty percent (50%) of the Purchase Price, adjusted for certain closing costs, was paid at closing, and the balance is due to the Sellers on the third anniversary of the closing date. The portion of the Purchase Price paid at closing was primarily financed by a loan of $3,149,081 (€2,900,000) pursuant to a Long Term Mezzanine Loan Agreement, dated August 18, 2015 (the “Loan Agreement”), by and among the Company, its wholly-owned subsidiary, Eastern Sphere Ltd. (“Eastern Sphere”), Eastern Sphere’s wholly-owned subsidiary, Bluesphere Italy, and Helios Italy Bio-Gas 1 L.P. On August 18, 2015, the Company and two of its wholly-owned subsidiaries, Eastern Sphere Ltd. (“Eastern Sphere”) and BlueSphere Italy, entered into a Long Term Mezzanine Loan Agreement (the “Helios Loan Agreement”) with Helios Italy Bio-Gas 1 L.P. (“Helios”). Under the Helios Loan Agreement, Helios will make up to $5,646,628 (€5,000,000) available to Bluesphere Pavia (the “Helios Loan”) to finance (a) ninety percent (90%) of the total required investment of the first four SVPs acquired, (b) eighty percent (80%) of the total required investment of up to three SVPs subsequently acquired, (c) certain broker fees incurred in connection with the acquisitions, and (d) any taxes associated with registration of an equity pledge agreement (as described below). Each financing of an SVP acquisition will be subject to specified conditions precedent and will constitute a separate loan under the Helios Loan Agreement. Helios may, within 90 days of a closing, require repayment of ten percent (10%) of the relevant loan and broker fees. If no such repayment is required, Helios may reduce the amount of its commitment to finance the acquisitions of the three additional SVPs to seventy to eighty percent (70-80%) of the total required investment. Helios’s commitment to provide any loan under the Helios Loan Agreement that is not utilized by June 30, 2016 will automatically cancel, unless extended in writing by Helios. Subject to specified terms, representations and warranties, the Helios Loan Agreement provides that each loan thereunder will accrue interest at a rate of 14.5% per annum, paid quarterly. Helios will also be entitled to an annual operation fee, paid quarterly. The final payment for each loan will become due no later than the earlier of (a) thirteen and one half years from the date such loan was made available to Bluesphere Italy, and (b) the date that the Feed in Tariff license granted to the relevant SVP expires. Pursuant to the Helios Loan Agreement and an equity pledge agreement, Eastern Sphere pledged all its shares in Bluesphere Pavia to secure all loan amounts utilized under the Helios Loan Agreement. The Company also entered into a no-interest bearing promissory note, dated December 8, 2015 (the “Palas Promissory Note”), with R.S. Palas Management Ltd. to finance a small portion of the Purchase Price. The Palas Promissory Note is for an amount of $129,146 (€118,000) and is due and payable, without interest or premium, on December 31, 2015. The payee under the Palas Promissory Note, R.S. Palas Management Ltd., is an entity owned and controlled by Shlomi Palas, the Company’s President and Chief Executive Officer and a member of its Board of Directors. In accordance with a Framework EBITDA Guarantee Agreement, dated July 17, 2015 (the “EBITDA Agreement”), between the Company and Austep S.p.A. (“Austep”), Austep will operate, maintain and supervise each biogas plant owned by the SPVs. In addition, Austep will guarantee a monthly aggregate EBITDA of $204,147 (€188,000) from the four SPVs for the initial six months following the acquisition, and thereafter Austep will guarantee an annual aggregate EBITDA of $4,082,946 (€3,760,000) from the four SPVs. Pursuant to the terms of the agreements with Austep, the Company will receive the guaranteed levels of EBITDA and Austep will receive any revenue in excess of these levels.	NOTE 3 – INVESTMENT IN BLUE SPHERE PAVIA On August 18, 2015, the Company and two of its wholly-owned subsidiaries, Eastern Sphere Ltd. (“Eastern Sphere”) and BlueSphere Italy, entered into a Long Term Mezzanine Loan Agreement (the “Helios Loan Agreement”) with Helios Italy Bio-Gas 1 L.P. (“Helios”). Under the Helios Loan Agreement, On December 14, 2015, and pursuant to a Share Purchase Agreement, dated May 14, 2015 (the “Share Purchase Agreement”), by and among the Company’s indirect wholly-owned subsidiary, Bluesphere Pavia (formerly called Bluesphere Italy S.r.l.) (“Bluesphere Pavia”), and Volteo Energie S.p.A., Agriholding S.r.l., and Overland S.r.l. (collectively, the “Sellers”), Bluesphere Pavia completed the acquisitions of one hundred percent (100%) of the share capital of Agricerere S.r.l., Agrielektra S.r.l., Agrisorse S.r.l. and Gefa S.r.l. (each, an “SPV” and collectively, the “SPVs”) from the Sellers. Each SPV owns and operates an anaerobic digestion biogas plant in Italy for the production and sale of electricity to Gestore del Servizi Energetici GSE, S.p.A., a state-owned company, pursuant to a power purchase agreement. Pursuant to the Italy Projects Agreement, the Company also issued a corporate guarantee to the Sellers, whereby the Company will secure the obligations of Bluesphere Pavia under the Italy Projects Agreement. Pursuant to the Share Purchase Agreement, the Company to pay $5,646,628 (€5,200,000) (the “Purchase Price”), subject to certain post-closing adjustments, to acquire the share capital of the SPVs. Fifty percent (50%) of the Purchase Price, adjusted for certain post-closing adjustments and closing costs, in the amount of $2,143,181 (€1,952,858) was paid at closing, and the balance is due to the Sellers on the third anniversary of the closing date. The portion of the Purchase Price paid at closing was primarily financed by a loan of $3,149,081 (€2,900,000) pursuant to the Helios Loan Agreement whereas the Company repaid $342,192 (€310,204) during the six months ended June 30, 2016. On or around December 2, 2015, the Company also received funds to finance a portion of the Purchase Price in the amount of $80,000 from a company in which a director of the Company serves as an officer. Such amount was not repaid as of June 30, 2016 and is classified as short-term debentures, notes and loans. In accordance with a Framework EBITDA Guarantee Agreement, dated July 17, 2015 (the “EBITDA Agreement”), between the Company and Austep S.p.A. (“Austep”), Austep will operate, maintain and supervise each biogas plant owned by the SPVs. In addition, Austep will guarantee a monthly aggregate EBITDA of $204,147 (€188,000) from the four SPVs for the initial six months following the acquisition, and thereafter Austep will guarantee an annual aggregate EBITDA of $4,082,946 (€3,760,000) from the four SPVs. Pursuant to the terms of the agreements with Austep, the Company will receive the guaranteed levels of EBITDA and Austep will receive half of the revenue in excess of these levels.	NOTE 2 – INVESTMENTS IN JOINT VENTURES On October 19, 2012, the Company signed definitive project agreements in respect of both the North Carolina and Rhode Island sites with Orbit Energy, Inc. (“Orbit”), pursuant to which the Company would be entitled to full ownership of each of the entities that owns the rights to implement the respective projects (Orbit Energy Charlotte, LLC in the case of the North Carolina project (“OEC”) and Orbit Energy Rhode Island, LLC in the case of the Rhode Island project (“OERI”)), subject to the satisfaction of certain conditions. North Carolina Project On November 19, 2014, The Company signed an amended and restated purchase agreement with Orbit for the North Carolina project (the “Amended OEC Purchase Agreement”). Subject to the terms of the Amended OEC Purchase Agreement, Orbit transferred ownership of OEC to the Company in exchange for a development fee of $900,000, reimbursement of $17,764 and an amount equal to 30% of the distributable cash flow from the North Carolina project after the project achieves a post-recoupment 30% internal rate of return computed on the basis of any and all benefits from tax credits, depreciation and other incentives of any nature. The Company also agreed to use high solid anaerobic digester units designed by Orbit (the “HSAD Units”) and to retain Orbit to implement and operate the HSAD Units for an annual management fee of $187,500 (the “OEC Management Fee”), subject to certain conditions. The Amended OEC Purchase Agreement provided that the Company had until December 15, 2014 to pay Orbit the development fee and reimbursement amount, which was extended to January 15, 2015 upon payment of $75,000. The Company did not pay Orbit the development fee and reimbursement amount and, pursuant to the terms of the Amended OEC Purchase Agreement, ownership of OEC reverted back to Orbit on January 15, 2015. On January 30, 2015, The Company entered into the Orbit Energy Charlotte, LLC Membership Interest Purchase Agreement by and among the Company, Orbit, Concord Energy Partners, LLC, a Delaware limited liability company (“Concord”), and OEC (the “New OEC Purchase Agreement”), pursuant to which (i) Concord purchased all of Orbit’s right, title and interest in and to the membership interests of OEC (the “OEC Interests”), (ii) Orbit abandoned all economic and ownership interest in the OEC Interests in favor of Concord, (iii) Orbit ceased to be a member of OEC and (iv) Concord was admitted as the sole member of OEC. Subject to the satisfaction of certain conditions by Orbit, The Company agreed to be responsible for all costs of evaluating and incorporating into the North Carolina project (i) Orbit’s high solids anaerobic digestion technology, consisting of a proprietary process that uses an anaerobic digester design developed by the U.S. Department of Energy and subsequently modified by Orbit in combination with the proprietary bacteria supplied by Orbit (the “Orbit Technology”), and (ii) two HSAD Units designed by Orbit with up to a total maximum capacity of 100 tons per day. The Company are responsible for both direct and indirect costs, all payments to be made to Orbit and all increased costs, expenses and any damages incurred in connection with the design, installation, integration, operation and maintenance of the Orbit Technology incorporated into the project. The Company also agreed to enter into an operations agreement with Orbit in respect of the HSAD Units to be integrated into the North Carolina project and to pay Orbit the OEC Management Fee. In a letter agreement executed in connection with the New OEC Purchase Agreement, The Company agreed to pay Orbit an amount equal to thirty percent (30%) of the North Carolina project’s distributable cash flow after The Company and the other equity investors in the North Carolina project fully recoup their respective investments in the North Carolina project (such investments to be calculated solely as amounts expended in and for the construction of the North Carolina project) and the North Carolina project achieves a thirty percent (30%) internal rate of return. The calculation of the project’s internal rate of return would take into account and be computed on the basis of any and all benefits from tax credits, depreciation and other incentives of any nature, as well as the OEC Management Fee. On the same date as the New OEC Purchase Agreement, (i) the Company, Concord and York Renewable Energy Partners LLC (“York”) entered into a development and indemnification agreement (the “Concord Development and Indemnification Agreement”), pursuant to which Concord paid the Company $1,250,000, issued the Company 250 Series B units of Concord (“Concord Series B Units”) and issued 750 Series A units of Concord (“Concord Series A Units”) to York, and (ii) The Company and York entered into an amended and restated limited liability company operating agreement (the “Concord LLC Agreement”) to establish the Concord Series A Units and Concord Series B Units and admit the Company and York as 25% and 75% members of Concord, respectively. Pursuant to the foregoing agreements, York also agreed to pay the Company two equal installments of $587,500 upon (a) mechanical completion of the North Carolina project and (b) commercial operation of the North Carolina project Company’s rights to receive distributions from Concord are subject to certain priorities in favor of York. In connection with the foregoing, on January 30 2015, the Company terminated its amended and restated construction finance agreement, dated June 6, 2014, with Caterpillar Financial Services Corporation. In February 2015, The Company received $1,586,000 for development fees and reimbursements in connection with the North Carolina project. If commercial operations are not commenced within 60 days of December 31, 2015, OEC will be required to pay $500,000 of liquidated damages to Duke Energy pursuant to the Duke PPA. If applicable, York will be responsible for contributing these funds to OEC. Although no assurances can be given, the Company expects the North Carolina project to commence commercial operations in the first quarter of 2016. Based on the investments made by York as of September 30, 2015, the Company’s portion of net equity in Concord amounted to a total of $3,616,978. Such amount was presented as an asset in the balance sheet and as deferred revenues from equity in subsidiaries. Such deferred revenues will be recorded to the profit and loss statement upon completion of the plants and fulfillment of all the Company’s obligation under the above agreements. Rhode Island Project On January 7, 2015, the Company signed an amended and restated purchase agreement with Orbit for the Rhode Island project (the “Amended OERI Purchase Agreement”). Subject to the terms of the Amended OERI Purchase Agreement, Orbit transferred full ownership of OERI to the Company in exchange for a development fee of $300,000, reimbursement of $86,432 and an amount equal to 30% of the distributable cash flow from the Rhode Island project after the project achieves a post-recoupment 30% internal rate of return computed on the basis of any and all benefits from tax credits, depreciation and other incentives of any nature. The Company also agreed to use HSAD Units designed by Orbit and to retain Orbit to implement and operate the HSAD Units for an annual management fee of $187,500 (the “OERI Management Fee”), subject to certain conditions. The Amended OERI Purchase Agreement provided that the Company had until January 22, 2015 to pay Orbit the development fee and reimbursement amount, which was extended to February 28, 2015 upon payment of $31,000. The Company did not pay the development fee and reimbursement amount and, pursuant to the terms of the Amended OERI Purchase Agreement, ownership of OERI reverted back to Orbit. On April 8, 2015, the Company entered into the Orbit Energy Rhode Island, LLC Membership Interest Purchase Agreement by and among the Company, Orbit, Rhode Island Energy Partners, LLC, a Delaware limited liability company (“Rhode Island”) and OERI (the “New OERI Purchase Agreement”), pursuant to which (i) Rhode Island purchased all of Orbit’s right, title and interest in and to the membership interests of OERI (the “OERI Interests”), (ii) Orbit abandoned all economic and ownership interest in the OERI Interests in favor of Rhode Island, (iii) Orbit ceased to me a member of OERI and (iv) Rhode Island was admitted as the sole member of OERI. Subject to the satisfaction of certain conditions by Orbit, the Company agreed to be responsible for all costs of evaluating and incorporating into the Rhode Island project (i) the Orbit Technology and (ii) two HSAD Units designed by Orbit with up to a total maximum capacity of 75 tons per day. The Company are responsible for both direct and indirect costs, all payments to be made to Orbit and all increased costs, expenses and any damages incurred in connection with the design, installation, integration, operation and maintenance of the Orbit Technology incorporated into the project. The Company also agreed to enter into an operations agreement with Orbit in respect of the HSAD Units to be integrated into the Rhode Island project and to pay Orbit the OERI Management Fee. The Company also acknowledged in the New OERI Purchase Agreement its continuing responsibility to pay Orbit an amount equal to thirty percent (30%) of the Rhode Island project’s distributable cash flow after the Company and the other equity investors in the Rhode Island project fully recoup Company’s respective investments in the Rhode Island project (such investments to be calculated solely as amounts expended in and for the construction of the Rhode Island project) and the Rhode Island project achieves a thirty percent (30%) internal rate of return. The calculation of the project’s internal rate of return would take into account and be computed on the basis of any and all benefits from tax credits, depreciation and other incentives of any nature, as well as the OERI Management Fee. On the same date as the New OERI Purchase Agreement, (i) the Company, Rhode Island and York entered into a development and indemnification agreement (the “Rhode Island Development and Indemnification Agreement”), pursuant to which Rhode Island agreed to pay the Company $1,481,900, issue the Company 2,275 Series B units of Rhode Island (“Rhode Island Series B Units), and issue 7,725 Series A units of Rhode Island (“Rhode Island Series A Units”) to York, and (ii) The Company and York entered into an amended and restated limited liability company operating agreement (the “Rhode Island LLC Agreement”) to establish the Rhode Island Series A Units and Rhode Island Series B Units and admit the Company and York as 22.75% and 77.25% members of Rhode Island, respectively. Pursuant to the foregoing agreements, York also agreed to pay the Company three equal installments of $562,500 upon (a) signing of the Rhode Island Development and Indemnification Agreement, (b) the later of (x) the date of mechanical completion of the Rhode Island project and (y) the date on which an executed interconnection agreement between OERI and National Grid, including receipt of any regulatory approvals from the Rhode Island Public Utility Commission, is delivered by OERI, and (c) commercial operation of the Rhode Island project. Based on the investments made by York as of September 30, 2015, the Company’s portion of net equity in Rhode Island amounted to a total of $1,335,377. Such amount was presented as an asset in the balance sheet and as deferred revenues from equity in subsidiaries. Such deferred revenues will be recorded to the profit and loss statement upon completion of the plants and fulfillment of all the Company’s obligation under the above agreements.

CONDENSED CONSOLIDATED FINANCIA

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS	3 Months Ended	6 Months Ended
	Dec. 31, 2015	Jun. 30, 2016
Condensed Consolidated Financial Statements
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS	NOTE 4 - INTERIM FINANCIAL STATEMENTS: The accompanying unaudited interim consolidated financial statements as of December 31, 2015 and for the three months then ended, have been prepared in accordance with accounting principles generally accepted in the United States relating to the preparation of financial statements for interim periods. Accordingly, they do not include all the information and footnotes required for annual financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended December 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2016. The September 30, 2015 Condensed Balance Sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. These financial statements should be read in conjunction with the financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended September 30, 2015.	NOTE 4 – CONDENSED CONSOLIDATED FINANCIAL STATEMENTS The accompanying unaudited condensed consolidated financial statements as of June 30, 2016 and for the six and three months then ended have been prepared in accordance with accounting principles generally accepted in the United States relating to the preparation of financial statements for interim periods. Accordingly, they do not include all the information and footnotes required for annual financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six and three months ended June 30, 2016 are not necessarily indicative of the results that may be expected for the year ending December 31, 2016. The September 30, 2015 Condensed Balance Sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. These financial statements should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended September 30, 2015.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2016	Sep. 30, 2015
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	NOTE 5 – SIGNIFICANT ACCOUNTING POLICIES: The significant accounting policies applied in the annual financial statements of the Company as of September 30, 2015, are applied consistently in these financial statements except for the following: a. Business combinations and Goodwill The Company accounts for its business combinations using the purchase method of accounting. Under this method, the Company allocates the purchase price to tangible and intangible assets acquired and liabilities assumed based on estimated fair values at the date of acquisition, with the excess of the purchase price amount being allocated to goodwill. Acquisition-related and integration costs associated to the business combination are expensed as incurred. Changes in estimates associated with future income tax assets after measurement period are recognized as income tax expense with prospective application to all business combinations regardless of the date of acquisition. Goodwill for each reporting unit is assessed for impairment at least annually, or when an event or circumstance occurs that more likely than not reduces the fair value of a reporting unit below its carrying amount. An impairment charge is recorded when the carrying amount of the reporting unit exceeds its fair value and is determined as the difference between the goodwill’s carrying amount and its implied fair value. b. Intangible Assets Intangible assets consist of allocated acquisition costs of power purchase agreements, which are amortized using the straight-line method over the 15 year terms of the agreements (see Note 3). c. Long-Lived Assets When events or changes in circumstances indicate that the carrying amount of long-lived assets, such as capital assets and intangible assets, may not be recoverable, undiscounted estimated cash flows are projected over their remaining term and compared to the carrying amount. To the extent that such projections indicate that future undiscounted cash flows are not sufficient to recover the carrying amounts of related assets, a charge is recorded to reduce the carrying amount to the projected future discounted cash flows. d. Revenue recognition Revenues related to the sale of electricity are recorded based upon output delivered and capacity provided at rates specified under relevant contract terms.	NOTE 5 – SIGNIFICANT ACCOUNTING POLICIES The significant accounting policies applied in the annual financial statements of the Company as of September 30, 2015, are applied consistently in these financial statements except for the following: a. Business combinations and Goodwill The Company accounts for its business combinations using the purchase method of accounting. Under this method, the Company allocates the purchase price to tangible and intangible assets acquired and liabilities assumed based on estimated fair values at the date of acquisition, with the excess of the purchase price amount being allocated to goodwill. Acquisition-related and integration costs associated to the business combination are expensed as incurred. Changes in estimates associated with future income tax assets after measurement period are recognized as income tax expense with prospective application to all business combinations regardless of the date of acquisition. Goodwill for each reporting unit is assessed for impairment at least annually, or when an event or circumstance occurs that more likely than not reduces the fair value of a reporting unit below its carrying amount. An impairment charge is recorded when the carrying amount of the reporting unit exceeds its fair value and is determined as the difference between the goodwill’s carrying amount and its implied fair value. Goodwill consists of allocated acquisition costs of PPAs, which are amortized using the straight-line method over the 15 year terms of the agreements (see Note 3). b. Intangible Assets Intangible assets consist of non-monetary and separately identifiable assets, which can be controlled and are expected to generate future economic benefits. Such assets are recognized at acquisition and/or production cost, including directly attributable expenses to make the asset ready for use, net of accumulated amortization charges and any impairment losses. The costs incurred internally to develop new services and platforms are considered intangible assets generated internally and are recognized as assets only if the following requirements are met: 1. the cost incurred for the development of the assets can be reliably measured; 2. the entity has the intention, the availability of financial resources, the ability to complete the assets and to use or sell them; 3. the entity has the intention, the availability of financial resources, the ability to complete the assets and to use or sell them; Capitalized development costs include only expenses incurred that can be directly attributed to the process of developing new products and services. Intangible assets with a finite useful life are amortized on a straight-line basis over their useful lives and are tested for impairment when circumstances indicate that the carrying value may be impaired. The amortization period and the amortization method for intangible assets with a finite useful lives are reviewed at least at each reporting date. Changes in expected useful lives, or in the way the future economic benefits will be generated by the assets, are either recognized through a change in the period or in the amortization method and are accounted for as changes in accounting estimates. The amortization charges for intangible assets with a finite useful life are classified in the statement of income, in the costs appropriate for the function of the related intangible assets. c. Long-Lived Assets When events or changes in circumstances indicate that the carrying amount of long-lived assets, such as capital assets and intangible assets, may not be recoverable, undiscounted estimated cash flows are projected over their remaining term and compared to the carrying amount. To the extent that such projections indicate that future undiscounted cash flows are not sufficient to recover the carrying amounts of related assets, a charge is recorded to reduce the carrying amount to the projected future discounted cash flows. d. Revenue recognition Revenues related to the sale of electricity are recorded based upon output delivered and capacity provided at rates specified under relevant contract terms.	NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES a. The currency of the primary economic environment in which the operations of the Company are conducted is the U.S dollar (“$” or “dollar”). Most of the Company’s expenses are incurred in dollars. Most of the Company’s external financing is in dollars. The Company holds most of its cash and cash equivalents in dollars. Thus, the functional currency of the Company is the dollar. Since the dollar is the primary currency in the economic environment in which the Company operates, monetary accounts maintained in currencies other than the dollar are re-measured using the representative foreign exchange rate at the balance sheet date. Operational accounts and non-monetary balance sheet accounts are measured and recorded at the rate in effect at the date of transaction. The effects of foreign currency re-measurement are reported in current operations (as “financial expenses - net) and have not been material to date. b. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Inter-company balances and transactions have been eliminated upon consolidation. c. Cash equivalents are short-term highly liquid investments which include short term bank deposit (up to three months from date of deposit), that are not restricted as to withdrawals or use that are readily convertible to cash with maturities of three months or less as of the date acquired. d. Property, plant and equipment are stated at cost, less accumulated depreciation. Assets are depreciated using the straight-line method over their estimated useful lives. Computers, software and electronic equipment are depreciated over three years. Tools and equipment are depreciated over five years. Furniture is depreciated over fourteen years. e. Investments in affiliated companies that are not controlled but over which the Company can exercise significant influence (generally, entities in which the Company holds approximately between 20% to 50% of the voting rights of the investee) are presented using the equity method of accounting. Profits on intercompany sales, not realized outside the Company, are eliminated. The Company discontinues applying the equity method when its investment (including advances and loans) is reduced to zero and the Company has not guaranteed obligations of the affiliate or otherwise committed to provide further financial support to the affiliate. Investments in preferred shares, which are not in substance common stock, are recorded on a cost basis according to ASC 323-10-15-13, “Investments - Equity Method and Joint Ventures - In-substance Common Stock” and ASC 323-10-40-1, "Investment -Equity Method and Joint Ventures - Investee Capital Transactions". A change in the Company’s proportionate share of an investee’s equity, resulting from issuance of common or in-substance common shares by the investee to third parties, is recorded as a gain or loss in the consolidated income statements in accordance with ASC 323-10-40-1. Investments in non-marketable equity securities of entities in which the Company does not have control or the ability to exercise significant influence over their operation and financial policies, are recorded at cost (generally when the Company holds less than 20% of the voting rights). Management evaluates investments in affiliated companies, partnerships and other non-marketable equity securities for evidence of other-than-temporary declines in value. Such evaluation is dependent on the specific facts and circumstances. Accordingly, in determining whether other-than-temporary declines exist, management evaluates various indicators for other-than-temporary declines and evaluates financial information (e.g. budgets, business plans, financial statements, etc.). During 2015 and 2014, no material impairment was recognized. f. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results may differ from those estimates g. Share-based payments to employees are measured at the fair value of the options issued and amortized over the vesting periods. Share-based payments to non-employees are measured at the fair value of the goods or services received or the fair value of the equity instruments issued if it is determined the fair value of the goods or services cannot be reliably measured, and are recorded at the date the goods or services are received. The amount recognized as an expense is adjusted to reflect the number of awards expected to vest. The offset to the recorded cost is to share-based payments reserve. Consideration received on the exercise of stock options is recorded as capital stock and the related share-based payments reserve is transferred to share capital. h. Net loss per share, basic and diluted, is computed on the basis of the net loss for the period divided by the weighted average number of common shares outstanding during the period. Diluted net loss per share is based upon the weighted average number of common shares and of common shares equivalents outstanding when dilutive. Common share equivalents include: (i) outstanding stock options under the Company’s share incentive plan and warrants which are included under the treasury share method when dilutive, and (ii) common shares to be issued under the assumed conversion of the Company’s outstanding convertible notes, which are included under the if-converted method when dilutive. The computation of diluted net loss per share for the years ended September 30, 2015, 2014, and 2013, does not include common share equivalents, since such inclusion would be anti-dilutive. i. Deferred taxes are determined utilizing the asset and liability method based on the estimated future tax effects of differences between the financial accounting and tax bases of assets and liabilities under the applicable tax laws. Deferred tax balances are computed using the tax rates expected to be in effect when those differences reverse. A valuation allowance in respect of deferred tax assets is provided if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company has provided a full valuation allowance with respect to its deferred tax assets. j. The Company has no component of comprehensive income loss other than net loss. k. The Company recognizes revenues from services rendered in accordance with ASC Topic 605-20 Revenue Recognition from Services. The Company records services to be supplied under contractual agreements as deferred revenue until such related services are provided. l. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Accounting Standards Codification (“ASC”) 605, Revenue Recognition. The new revenue recognition standard requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. In August 2015, the FASB issued Accounting Standards Update No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, or ASU 2015-14. This amendment defers the effective date of the previously issued Accounting Standards Update ASU 2014-09, until the interim and annual reporting periods beginning after December 15, 2017. Earlier application is permitted for interim and annual reporting periods beginning after December 15, 2016. If the Company begins generating revenue prior to the effective date of ASU 2015-14, the Company will evaluate the effect that ASU 2014-09 will have on the results of operations and financial position. In August 2015, the FASB has issued Accounting Standards Update (ASU) No. 2015-15, Interest - Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements - Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting . This ASU adds SEC paragraphs pursuant to the SEC Staff Announcement at the June 18, 2015, Emerging Issues Task Force meeting about the presentation and subsequent measurement of debt issuance costs associated with line-of-credit arrangements. Given the absence of authoritative guidance within ASU 2015-03 for debt issuance costs related to line-of-credit arrangements, the SEC staff would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. The Company does not expect this update will have a material impact on the presentation of the Company’s consolidated financial position, results of operations and cash flows. In September 2015, the FASB issued ASU 2015-16, Business Combinations (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments, which eliminates the requirement to retrospectively account for changes to provisional amounts initially recorded in a business acquisition opening balance sheet. Prior to the issuance of ASU 2015-16, an acquirer was required to restate prior period financial statements as of the acquisition date for adjustments to provisional amounts. This guidance is effective for fiscal years beginning after December 15, 2015, including interim periods within fiscal years. The Company is evaluating the effect, if any, this update will have on the Company’s consolidated financial position, results of operations and cash flows. In November 2015, the FASB has issued Accounting Standards Update (ASU) No. 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes, which changes how deferred taxes are classified on organizations’ balance sheets. The ASU eliminates the current requirement for organizations to present deferred tax liabilities and assets as current and noncurrent in a classified balance sheet. Instead, organizations will be required to classify all deferred tax assets and liabilities as noncurrent. The amendments apply to all organizations that present a classified balance sheet. For public companies, the amendments are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company does not expect this update will have a material impact on the presentation of the Company’s consolidated financial position, results of operations and cash flows.

GOING CONCERN

GOING CONCERN	3 Months Ended	6 Months Ended
	Dec. 31, 2015	Jun. 30, 2016
Going Concern [Abstract]
GOING CONCERN	NOTE 6 – GOING CONCERN The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As of December 31, 2015, the Company had approximately $2,732 thousand in cash and cash equivalents, approximately $17,191 thousand in negative working capital, a stockholders’ deficit of approximately $3,689 thousand and an accumulated deficit of approximately $44,701 thousand. Management anticipates their business will require substantial additional investments that have not yet been secured. The Company anticipates that the existing cash will not be sufficient to continue its operations through the next 12 months. Management is continuing in the process of fund raising in the private equity markets as the Company will need to finance future activities and general and administrative expenses. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Company’s ability to continue as a going concern is dependent upon raising capital from financing transactions and revenue from operations. These financial statements do not include any adjustments that may be necessary should the Company be unable to continue as a going concern. The Company’s continuation as a going concern is dependent on its ability to obtain additional financing as may be required and ultimately to attain profitability.	NOTE 6 – GOING CONCERN The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As of June 30, 2016, the Company had approximately $1,280,000 in cash and cash equivalents, approximately $14,456,000 in negative working capital, a stockholders’ deficit of approximately $8,287,000 and an accumulated deficit of approximately $51,916,000. Management anticipates their business will require substantial additional investments that have not yet been secured. Management is continuing in the process of fund raising in the private equity markets as the Company will need to finance future activities. The Company’s ability to continue as a going concern is dependent upon raising capital from financing transactions and revenue from operations. These unaudited financial statements do not include any adjustments that may be necessary should the Company be unable to continue as a going concern. The Company’s continuation as a going concern is dependent on its ability to obtain additional financing as may be required and ultimately to attain profitability.

NEWLY ISSUED ACCOUNTING PRONOUN

NEWLY ISSUED ACCOUNTING PRONOUNCEMENTS	3 Months Ended	6 Months Ended
	Dec. 31, 2015	Jun. 30, 2016
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
NEWLY ISSUED ACCOUNTING PRONOUNCEMENTS	NOTE 7 - NEWLY ISSUED ACCOUNTING PRONOUNCEMENTS: No new accounting standards have been adopted since the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2015 was filed.	NOTE 7 – NEWLY ISSUED ACCOUNTING PRONOUNCEMENTS No new accounting standards have been adopted since the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2015 was filed.

COMMON SHARES

COMMON SHARES	3 Months Ended	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2016	Sep. 30, 2015
Stockholders' Equity Note [Abstract]
COMMON SHARES	NOTE 8 – COMMON SHARES: On October 21, 2015 the Company issued 1,630,000 shares of common stock of the Company for the aggregate purchase price of $48,000. Such issuance was made pursuant to the April 15, 2015, Subscription Agreement with Dr. Borenstein Ltd. (the "April Borenstein Subscription Agreement"). On October 21, 2015 the Company issued 8,484,848 shares of common stock of the Company for the aggregate purchase price of $140,000. Such issuance was made pursuant to the April 15, 2015, Subscription Agreement with Dr. Borenstein Ltd. (the "April Borenstein Subscription Agreement"). On October 26, 2015 and December 2, 2015, the Company issued 2,060,000 shares of common stock to a consultant in respect of his investor relations and public relations services consulting agreements with the Company. The Company has estimated the fair value of such shares, and recorded an expense of $40,579. On October 12, 2015, the Company issued 375,000 shares of common stock to a consultant in respect of its general advisory services and strategic planning consulting agreement with the Company. The Company has estimated the fair value of such shares, and recorded an expense of $8,438.	NOTE 8 – COMMON SHARES On January 26, 2016, the Company issued 1,000,000 shares of common stock pursuant to a subscription agreement dated June 12, 2015. On February 1, 2016 the Company issued 540,000 shares of common stock to a consultant in respect of his consulting services for the Company. The Company has estimated the fair value of such shares, and recorded an expense of $36,126. In February 2016, the Company conducted an offering (the “February Offering”) consisting of (a) up to USD $1,925,000 of the Company’s shares of common stock, par value $0.001 per share (“Common Stock”), priced at the closing price for shares of Common Stock, as reported on the OTCQB Venture Marketplace, on the trading day prior to the closing of the February Offering, and (b) 5-year warrants to purchase shares of Common Stock in an amount equal to 50% of the number of shares of Common Stock so purchased by the subscriber (the “February Warrants”, together with the shares of Common Stock subscribed for, the “February Securities”). The February Securities have been offered pursuant to subscription agreements with each investor (the “February Subscription Agreement”). In addition to other customary provisions, each February Subscription Agreement provides that the Company will use its reasonable commercial efforts to register all shares of Common Stock sold in the February Offering, including all shares of Common Stock underlying the February Warrants, within 60 days of the closing of the February Offering. The February Warrants are exercisable for 5 years from the date of issuance at $0.10 per share, include an option by which the holder may exercise the February Warrant by means of a cashless exercise, and include customary weighted-average price adjustment and anti-dilution terms. On February 15, 2016, the Company completed the only closing of the February Offering, representing aggregate gross proceeds to the Company of $1,925,000. In connection with the closing, the Company and subscribers entered into (a) February Subscription Agreements for, in the aggregate, 35,000,000 shares of Common Stock at $0.055 per share, and (b) February Warrants to purchase, in the aggregate, up to 17,500,000 shares of Common Stock at an exercise price of $0.10 per share. The warrants were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $933,358 at the date of issuance and using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 Risk-free interest rate 1.20 % Expected term (years) 5 Volatility 203 % The Company engaged Maxim Group LLC (“Maxim”) to assist in the February Offering. Pursuant to the terms of an engagement letter between Maxim and the Company, Maxim received commissions equal to 7% of the gross proceeds raised by Maxim in the February Offering, warrants to purchase, in the aggregate, up to 2,800,000 shares of Common Stock at an exercise price of $0.0605 per share and to purchase, in the aggregate, up to 1,400,000 shares of Common Stock at an exercise price of $0.11 per share. The Company has estimated the fair value of such warrants at a value of $224,413 at the date of issuance and using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 Risk-free interest rate 1.20 % Expected term (years) 5 Volatility 203 % On March 15, 2016, the Company issued 85,000 shares of common stock to a consultant in respect of his consulting services for the Company. The Company has estimated the fair value of such shares, and recorded an expense of $5,687. On April 13, 2016, the Company issued 1,000,000 shares of common stock of the Company to a consultant in consideration for corporate finance, investor communications and financial and investor public relations services. On June 13, 2016 and per the consulting agreement the Company issued an additional 1,000,000 shares of common stock as a service bonus since the agreement was not terminated prior to June 9, 2016. The Company has estimated the fair value of such shares, and recorded an expense of $165,400. On April 13, 2016, we issued an aggregate of 875,000 shares of our common stock to a consultant, pursuant to consulting agreements dated September 1, 2015 and March 1, 2016, in consideration for investment banking, business and financial consulting, investor relations and communications and operational executive management services. On May 18, 2016, a 1.5-year warrant to purchase shares of common stock, dated May 4, 2015, was exercised into 700,000 shares of common stock at an exercise price of $0.058 per share, for total consideration of $40,235. On June 2, 2016, the Company issued 13,930,742 shares of common stock in consideration for loans in the amount of $145,526 that were received to finance a portion of the acquisitions of one hundred percent (100%) of the SPVs. On June 13, 2016, the Company issued 7,103,467 shares of common stock of the Company to several officers, directors, employees and/or consultants of the Company. All shares were issued pursuant to the Company’s Global Share and Options Incentive Enhancement Plan (2014) (the “2014 Incentive Plan”) and the Company’s Global Share Incentive Plan (2010). The Company has estimated and recorded the fair value of such shares as an expense of $585,326 which was recorded through the vesting periods. On June 13, 2016, the Company issued 850,000 shares of common stock of the Company to a consultant in consideration for investment banking, business and financial consulting, investor relations and communications and operational executive management. The Company has estimated the fair value of such shares, and recorded an expense of $72,625. On June 26, 2016, the Company issued 500,000 shares of common stock of the Company in order to complete its obligations under the Share Purchase Agreement from 2015.	NOTE 6 – COMMON SHARES: On October 25, 2012 the Company entered into a Subscription Agreement with a non-US investor for the sale of 88,496 shares of common stock for an aggregated amount of $20,000. On October 25, 2012 the Company entered into an agreement with a non-US investor to sell 380,531 shares of common stock for an aggregated amount of $50,000. On November 5, 2012 the Company entered into an agreement with a non-US investor to sell 265,487 shares of common stock at December 25, 2012 for an aggregated amount of $70,000. On November 5, 2012 the Board of Directors of the Company approved the issuance of 53,098 shares of the Company to its Chief Executive officer, 44,248 shares to the Chairman of the Board, 44,248 shares to the Executive Vice-President and 35,399 shares to the Chief Carbon Officer and general counsel of the Company. On November 20, 2012, the Company agreed to issue 331,859 shares of the Company. Such shares have been issued on January 11, 2013 and were valued based on the share price of the Company to be $101 thousands. On December 20 2012, the Company entered into an agreement with a non-US investor to sell 309,735 shares of common stock at a price of $0.32286 per share for $100,000 and to purchase another 154,868 shares of common stock for $50,000 in January 2013 and another 154,868 shares of common stock for $50,000 in February 2013. Additionally, the Company was (i) obligated to issue such investor 88,496 shares of common stock in February 2013 at no additional cost and (ii) issue to such investor an option to purchase 66,372 shares of common stock for one year for 2.26 per share and to purchase 66,372 shares of common stock for two years at a price per share of $4.52. The Company has estimated the aggregate fair value of such options granted using the Black-Scholes option pricing to be approximately $76,000. On January 3, 2013, the Company signed a consulting agreement with Emerging Market Consulting, LLC (the “EMC”). According to the agreement, EMC would assist the Company with the design, development and dissemination of corporate information for a period of three month with an option to extend the agreement for an additional nine months. The Company paid EMC $11,000 and issued 39,824 restricted shares of the Company common stock, for the first period. The Company evaluated the cost of such issuance based on the share price of the Company to be $11 thousand. The Company elected not to renew the agreement and the agreement expired on April 3, 2013. On February 2, 2013 the Company issued 451,328 shares of common stock to an investor for an aggregate amount of $50,000. On February 19, 2013, the Company signed a subscription agreement with a non-US investor pursuant to which such investor agreed to invest an aggregate of $75,000 into the Company in three installments: (i) $25,000 on March 10, 2013, (ii) $25,000 on April 10, 2013 and (iii) $25,000 on May 10, 2013. For each $25,000 invested, the Company was obligated to issue 88,496 shares of common stock to the investor. As of September 30, 2013 the investor transferred to the Company all three installments and the Company issued to the investor 265,487 shares. In addition, the non-US investor invested an additional $25,000 for an additional 88,496 shares of common stock of the Company. On February 20, 2013, the Company signed a subscription agreement with a non-US investor pursuant to which such investor agreed to invest an aggregate of $50,000 into the Company in three installments: (i) $16,600 on March 10, 2013, (ii) $16,600 on April 10, 2013 and (iii) $16,700 on May 10, 2013. Upon receipt of each installment, the Company was obligated to issue 146,903 shares of common stock to the investor. As of September 30, 2013, the Company received all three installments totaling $50,000 and issued 440,708 shares. Additionally, on May 23, 2013 the Company issued 35,399 shares of the Company for $4,000 to the non-US investor under the same terms of the agreement above. On March 18, 2013 the Board of Directors of the Company approved the issuance of 53,098 shares of the Company to its Chief Executive Officer, 44,248 shares to the Chairman of the Board, 44,248 shares to the Executive Vice-President and 35,399 shares to the Chief Carbon Officer and general counsel of the Company. On April 30, 2013 the Board of Directors of the Company approved the issuance of 230,089 shares of the Company and 203,089 options to its Chief Executive officer, 203,540 shares and 203,540 options to the Chairman of the Board, 168,142 shares and 168,142 options to the Executive Vice-President and 88,496 shares and 88,496 options to both the Chief Carbon Officer and general counsel of the Company and for the CTO of Company. The shares and options will vest over a two year period with 1/8 of the total amount of the shares and options vesting at the end of each quarter from the date of the grant. In May and July 2013, the Company issued 495,576 shares of common stock to an investor for an aggregate amount of $49,315. On June 19, 2013 the Board of Directors of the Company approved the issuance of 53,098 shares of the Company to its Chief Executive officer, 44,248 shares to the Chairman of the Board, 44,248 shares to the Executive Vice-President and 35,399 shares to the Chief Carbon Officer and general counsel of the Company. On June 19, 2013 the Company entered into an agreement with a third party. In exchange for his services the Company issued the third party 176,992 shares of common stock of the Company. On June 23, 2013, the Company signed an additional agreement with the third party according to which the Company issued additional 156,611 shares of common stock of the Company. On June 19, 2013 the Company entered into an agreement with a non-US investor to sell 132,744 shares of common stock for an aggregate amount of $50,000. On June 19, 2013 the Company entered into an agreement with a non-US investor to sell 53,634 shares of common stock for an aggregate amount of $20,000. On June 26, 2013 the Company entered into an agreement with a non-US investor to sell 53,098 shares of common stock for an aggregate amount of $20,000. On June 26, 2013 the Company signed a Capital Markets Advisory Consulting Agreement with Incline Partners, LLC (“Incline”). According to the agreement, Incline agreed to provide the Company with capital market advisory and monthly distribution of articles and media for a period between June 15, 2013 through August 15, 2013. In consideration for the above services, the Company paid Incline a cash payment of $28,000 and issued 88,496 restricted shares of the Company common stock. On July 22, 2013 the Company entered into an agreement with a non-US investor to sell 268,169 shares of common stock for an aggregate amount of $100,000. On September 3, 2013 the Company entered into an agreement with a non-US investor to sell 268,169 shares of common stock for an aggregate amount of $100,000. On October 13, 2013 a non-US investor converted $87,000 principal loan for 384,956 shares of the Company’s common stock. On October 13, 2013, a non-US investor converted $37,000 principal loan for 163,717 shares of the Company’s common stock. During October 2013, holders of $47,878 of principal amount of Asher convertible notes converted their notes into 402,276 shares of the Company’s common stock. On October 8, 2013, the Company issued 88,496 shares of common stock for consulting services. On November 5, 2013, the Company’s subsidiary, Eastern Sphere, Ltd., entered into an agreement with an investor providing for the issuance of 491,642 shares of the Company’s common stock in consideration for $100,000. On November 14, 2013, the Company’s subsidiary, Eastern Sphere, Ltd., entered into an agreement with an investor providing for the issuance of 146,016 shares of the Company’s common stock in consideration for $29,107. On December 4, 2013, the Company entered into an agreement with an investor that agreed to provide collateral in the amount of $480,000 (€353,200) to enable the Company to receive a letter of credit in respect of the Company’s North Carolina project. In consideration for providing the collateral, the investor shall be entitled to a 4% ownership stake in the North Carolina project companies and was issued 44,248 shares of the Company’s common stock. Mr. Shlomi Palas personally guaranteed the Company’s obligations under the agreement with the investor. In addition, in accordance with the agreement, the Company issued to the investor a convertible note due on March 4, 2014 in the principal amount of $480,000 (€353,200) bearing interest at 1% per month, payable on a monthly basis. On or after March 4, 2014, any outstanding and unpaid principal under the convertible note is convertible into the Company’s shares of common stock based on the then applicable market price of the Company’s shares. The Company and the investor have verbally agreed to extend the maturity of such convertible note indefinitely and, in the meantime, the Company continues to make 1% interest payments on a monthly basis. On December 13, 2013 the Board of Directors of the Company approved the issuance of 424,779 shares of the Company to its Chief Executive Officer, 353,982 shares to the Chairman of the Board, 353,982 shares to the Executive Vice-President and 283,186 shares to the Chief Carbon Officer and general counsel of the Company. Such shares were issued at January 9, 2014. On December 15, 2013, the Company agreed to issue 600,000 shares of common stock to a consultant providing investor relation services. The shares are to be issued in three tranches of 200,000 each, the first within 10 days of entering into the agreement, the second on the four month anniversary of the agreement and the final on the eight month anniversary of the agreement. The first tranche of 200,000 shares was issued on January 9, 2014. During October 2014, the Company terminated the investor relation service agreement. On January 9, 2014, the Company issued 265,486 shares of common stock to an investor for $25,000 in cash. On January 9, 2014, the Company issued 345,132 shares of common stock for consulting services. The Company has estimated the fair value of such shares and recorded an expense of $89,734. On January 9, 2014, the Company issued 17,700 shares of common stock for consulting services. The Company has estimated the fair value of such shares and recorded an expense of $4,602. On January 26, 2014, the Company signed a subscription agreement with Talya Levy-Tytiun (“Talya”) pursuant to which Talya agreed to invest an aggregate of $400,000 into the Company for the sale of 1,739,130 shares of common stock. The Company was obligated to issue Talya additional shares of the Company, if, six months from the date of the agreement her ownership in the Company would be reduced below 12.3%. In addition, the Company guaranteed that if on the first anniversary of the agreement, the share price of the Company common stock was 0.23$ per share or less, the Company shall transfer Talya such amount necessary to make Talya whole and reimburse her for any loss due to her investment. On September 17, 2014 the Company issued Talya 2,866,194, shares of common stock as a reimbursement under the above agreement. On February 7, 2014, the Company issued an aggregate of 1,200,000 shares of its common stock to CTW – Changing the World Technologies, Ltd. (“CTW”) in exchange for (i) an investment of $77,000 (for which CTW received 385,000 shares of common stock) and (ii) the provision of financial engineering services (for which CTW received 815,000 shares of common stock). On March 5, 2014 Eastern Institutional Funding, LLC purchased $68,750 of the Company’s 20% notes due one year from such date that are convertible into shares of the Company’s common stock at a discount of 50% from the lowest trade price over the last 20 days from the date of conversion. On March 21, 2014, Capitoline Ventures II, LLC purchased $68,750 of the Company’s 20% notes due one year from such date that are convertible into shares of the Company’s common stock at a discount of 50% from the lowest trade price over the last 20 days from the date of conversion. As of June 30, 2014, the Company issued 5,114,073 shares of common stock in respect of the above notes and the remaining 1,320,000 shares were issued on July 2014. On March 10, 2014 the Board of Directors of the Company approved the issuance of 250,000 shares of the Company to its Chief Executive Officer, 220,000 shares to the Chairman of the Board, 200,000 shares to the Executive Vice-President and 180,000 shares to the Chief Carbon Officer and general counsel of the Company. On April 22, 2014 the Company signed a Consulting Services Agreement with a non-US person pursuant to which, the Company agreed to issue 4,000,000 shares of its common stock in exchange for consulting services to include, but not be limited to, advice on investor relations, public relations, transaction structuring, ongoing introductions to investors and strategic initiatives. The agreement is effective for one year commencing September 1, 2013. During the third quarter of 2014, the Company issued 3,350,000 shares of common stock in the Company. The Company has estimated the fair value of such shares and recorded an expense of $612,700. During the third quarter of 2014, the Company signed several investment agreements according to which the Company issued 880,000 shares of common stock the Company for total consideration of $109,721 in cash. In addition, the investors received options to purchase 822,500 shares of common stock of the Company for an exercise price of 0.10 cent per share. During the third quarter of 2014, the Company signed several investment agreements according to which the Company issued 759,041 shares of common stock the Company for total consideration of $77,127 in cash. In addition, the investors received options to purchase 759,041 shares of common stock of the Company for an exercise price of 0.10 cent per share and 759,041 shares of common stock of the Company for an exercise price of 0.13 cent per share. During the third quarter of 2014, the Company signed several investment agreements according to which the Company issued 352,805 shares of common stock the Company for total consideration of $98,784 in cash. In addition, the investors received options to purchase 352,805 shares of common stock of the Company for an exercise price of 0.60 cent per share. On May 1, 2014, the Company signed a consulting agreement with an investor according to which the company shall issue 2,819,000 shares of common stock of the Company and warrants to purchase 1,193,000 shares of common stock of the Company at an exercise price of $0.10 for one year commencing May 1, 2014. On September 22, 2014 the Company issued the consultant, 2,484,000 shares of common stock of the Company under the above agreement. In addition, on September 22, 2014 the Company issued 963,000 shares of common stock the Company to the consultant, for total cash consideration of $52,708. In addition, on May 1, 2014 the Company signed an agreement with the consultant according to which the consultant would provide investor relations services for a period of 12 months. Based on the agreement the Company issued the consultant 300,000 shares of the Company and 1,500,000 options to purchase shares of the Company at an exercise price of 0.10 cent per share. The options expire after 5 years. In addition, the Company agreed to issue 500,000 additional shares upon fulfillment of other conditions set in the agreement. The Company evaluated the fair value of the 300,000 shares and 1,500,000 options issued at $90,000 and $151,434, respectively. On May 2, 2014 the Company signed an agreement with a consultant according to which the consultant would provide investor relations services for a period of 12 months. Based on the agreement the Company issued the consultant 211,084 shares of the Company. The Company evaluated the fair value of the 211,084 shares and recorded an expense of $41,518. On May 25, 2014 the Company signed an agreement with a consultant according to which the consultant would provide investor relations services for a period of 6 months. Based on the agreement the Company issued the consultant 350,000 shares of the Company and 350,000 warrants to purchase shares of the Company at an exercise price of 0.20 cent per share. The options expire after 6 month. In addition, the Company agreed to issue 150,000 additional shares after 6 month from the date of the agreement and additional 150,000 shares for $0.20 per share, and pay the consultant NIS 18,000 per month during the agreement term. The Company evaluated the fair value of the 300,000 shares at $54,600. In addition the company recorded an expense related to the warrants issued of $28,310. On June 1, 2014 the Company signed an investment agreement with a third party according to which the Company issued 179,856 shares of common stock the Company for total consideration of $28,874 in cash. In addition, the investor received options to purchase 179,856 shares of common stock of the Company for an exercise price of 0.25 cent per share. During the third quarter of 2014, the Company signed several investment agreements according to which the Company issued 199,039 shares of common stock the Company for total consideration of $19,904 in cash. In addition, the investors received options to purchase 199,039 shares of common stock of the Company for an exercise price of 0.13 cent per share and 199,039 shares of common stock of the Company for an exercise price of 0.16 cent per share. On June 18, 2014 the Company signed an advisory board agreement with an accredited investor according to which the investor will serve on the Company’s advisory board for a period of one year from the date of the agreement unless otherwise extended by the parties. For his services, the advisor is entitled to 150,000 shares of the Company’s common stock of which75,000 vest on the date of the agreement and the remaining amount in three quarterly 25,000 shares, beginning 90 days from the date of the agreement. In addition the advisor is entitled to receive 150,000 warrants of the Company’s common stock. The warrants vest in 4 equal amounts over a period of twelve (12) months, the initial amount vesting on the agreement date. The warrants will allow the director to purchase the common stock of the Company for a period of 3 years from the agreement date. The warrants shall be exercisable in the following amounts: 1/3 at $0.30 a share, 1/3 at $0.40 a share, and 1/3 at $0.50 a share. In the event the advisor ceases to be a member of Board at any time during the vesting period for any reason, then any unvested warrants or unvested shares shall be irrefutably forfeited. On July 10, 2014 the Company issued 75,000 shares on account of such agreement. The Company evaluated the fair value of the shares and warrants and recorded an expense of $52,800. At April and June 2014 the Company signed three agreements with a non-US investor who provided the Company with several loans amounted to $78,400, according to which the investor converted his balance of loans into 800,892 shares of common stock of the Company. In addition, the Company issued the non-US investor invested 380,435 shares of common stock of the Company for total cash consideration of $69,000. On July 3, 2014 the Company issued 1,250,000 shares of common stock the Company to an investor for total cash consideration of $75,000. On July 29, 2014 the Company issued 144,054 shares of common stock the Company to an investor for total cash consideration of $34,522. In addition, the investor received options to purchase 144,054 shares of common stock of the Company for an exercise price of 0.10 cent per share. During April 2015 the investor exercised his option and the Company issued additional 144,054 shares. During April 2015, a non-US investor exercised his warrants to purchase shares of common stock of the Company for total consideration of $48,549. On May 27, 2015 the Company issued consultant 180,000 shares of common stock of the Company in respect of his 2014 consulting agreement with the Company. The Company has estimated the fair value of such shares and recorded an expense of $7,560. During July 2014, the Company issued a non-US investor 190,000 shares of common stock pursuant to a convertible loan agreement dated June 2013. During July and August 2014, the Company issued a non-US investor 3,969,133 shares of common stock of the Company, of which 650,000 were issued pursuant to the April 22, 2014 Consulting Services Agreement signed with the non-US person and the remaining were issued pursuant to the August 21, 2014 consulting agreement. The Company has estimated the fair value of such shares and recorded an expense of $970,573. On July 10, 2014 a loan in the amount of $24 thousand amount was converted into 115,000 shares of the Company. In addition, the Company granted the investor additional 75,000 shares for granting the loan. During July through September, 2014 the Company issued a consultant, 2,177,000 shares of common stock of the Company under his September 10, 2013 and April 22, 2014 consulting agreements. The Company has estimated the fair value of such shares and recorded an expense of $481,810. On September 21, 2014, the Company issued 280,592 shares of common stock of the Company for total cash consideration of $59,000. On September 21, 2014 the Company issued 48,183 shares of common stock the Company for total cash consideration of $11,557. In addition, the investor received options to purchase 48,183 shares of common stock of the Company for an exercise price of 0.32 cent per share. On October 28, 2014 the Company issued 335,000 shares of the Company’s common stock, in connection with the May 1, 2014 service agreement. During October, 2014, Asher converted $42,500 principal amount out of the April 11, 2014 notes for 471,967 shares of the Company’s common stock. On December 8, 2014 the Company issued 209,041 shares of the Company’s common stock to Carter Terry, in connection with the issuance of as detailed in note 4 above. On October 3, 2014 the Company signed a consulting agreement with a non-US citizen according to which the consultant would provide investor relation and public relations services for a period of one year. The Company agreed to grant the consultant 2,000,000 shares of the Company and additional 500,000 options to purchase Company's shares at an exercise price of $0.001 per shares. Such shares were issued on March 19, 2015. In addition, on the same date the Company issued the consultant 500,000 shares of the Company for the exercised of the options granted. The Company has estimated the fair value of such shares and options, and recorded an expense of $216,828. On January 5, 2015 the Company signed a consulting agreement with Dr. Borenstein Ltd according to which the company issued the consultant 1,000,000 options to purchase 1,000,000 shares of common stock of the Company at an exercise price of $0.001 for one year commencing the date of the agreement. The Consultant exercised such options at May 27, 2015. The Company has estimated the fair value of such options, and recorded an expense of $158,024. On February 28, 2015 and March 19, 2015 the Company issued 6,114,867 shares of the Company the consultant in respect of his September 2014 consulting investor relation and public relations services agreement with the Company. The Company has estimated the fair value of such shares, and recorded an expense of $738,353. On March 12, 2015 the Company issued 109,039 shares of the Company for an investor pursuant to the exercise of his options granted at May 2014. The Company has estimated the fair value of such shares, and recorded an expense of $14,103. In May and June 2015, the Company issued 3,765,000 shares of the Company to a consultant in respect of his investor relations and public relations services pursuant to a consulting agreement with the Company. The Company has estimated the fair value of such shares, and recorded an expense of $150,118. In May 2015, the Company issued 3,250,000 shares of the Company to a consultant in respect of his investor relations and public relations services pursuant to a consulting agreement with the Company. The Company has estimated the fair value of such shares, and recorded an expense of $136,500. On June 15, 2015 the Company issued consultant 1,500,000 shares of common stock of the Company in mutual agreement for termination of his June 2014 consulting agreement. The Company has estimated the fair value of such shares, and recorded an expense of $34,500. From July through September 2015, the Company issued 8,035,000 shares of common stock to a consultant in respect of his investor relations and public relations services consulting agreement with the Company. The Company has estimated the fair value of such shares, and recorded an expense of $198,614. In August 2015, the Company issued 3,474,405 shares of the Company to Maxim Group LLC in respect of its financial advisor and investment banker agreement with the Company. The shares have been valued at $34,397. In August 2015, the Company issued 1,128,237 shares of the Company to a non-U.S. person in respect of its financial advisor and investment banker settlement agreement with the Company. The Company has estimated the fair value of such shares, and recorded an expense of $13,088. On April 13, 2015, the Company entered into a subscription agreement with a non-U.S. person pursuant to which the Company issued 416,667 shares of common stock in exchange for $25,000. On April 15, 2015, the Company entered into a Subscription Agreement with Dr. Borenstein Ltd. (the “April Borenstein Subscription Agreement”) pursuant to which the Company agreed to sell 1,630,000 shares of common stock of the Company for the aggregate purchase price of $48,000. Such shares have been issued after the balance sheet date. On June 12, 2015, the Company entered into a Subscription Agreement with Dr. Borenstein Ltd. (the “June Borenstein Subscription Agreement”) pursuant to which the Company agreed to sell 8,484,848 shares of common stock of the Company for the aggregate purchase price of $140,000. Such shares have been issued after the balance sheet date. On July 1, 2015, the Company entered into a subscription agreement with a non-U.S. person pursuant to which the Company issued 2,000,000 shares of common stock in exchange for $32,000. On July 6, 2015, the Company entered into a subscription agreement with several non-U.S. entity pursuant to which the Company issued 2,428,571 shares of common stock in exchange for $51,000. On July 17, 2015, the Company entered into a subscription agreement with several non-U.S. personnel pursuant to which the Company issued 2,318,183 shares of common stock in exchange for $39,394. From February through August 2015, convertible promissory notes holders representing an aggregate principal amount of $1,480,716 converted their notes into 75,060,414 shares of the Company’s common stock. Share Repurchase Program On June 17, 2015, the Company’s Board of Directors approved a share repurchase program (the “Share Repurchase Program”). Under the Share Repurchase Program, the Company is authorized to repurchase up to $500,000 worth of its common stock, which, based on the value of the Company’s common stock on September 30, 2015, equates to approximately 16,666,667 shares of common stock. However, the total number of shares could differ based on the ultimate price per share paid by the Company. Further, the Company’s shares of common stock may be purchased on the open market or through privately negotiated transactions from time-to-time and in accordance with applicable laws, rules and regulations. The Company is not obligated to make any purchases, including at any specific time or in any particular situation. The program may be limited or terminated at any time without prior notice. As of September 30, 2015, the Company had not repurchased any shares under the Share Repurchase Program. On June 23, 2015, the Company repurchased 144,054 shares from a shareholder for $28,328 as part of a settlement with such shareholder. This repurchase was not pursuant to the Share Repurchase Program. Reverse stock split On November 26, 2013, the Company amended and restated its Articles of Incorporation to authorize the issuance of 500,000,000 shares of preferred stock, $0.001 par value, in one or more series and with such rights, preferences and privileges as its Board of Directors may determine and to effect a 1 for 113 reverse stock split of the Company’s outstanding common stock. In addition, the Amended and Restated Articles of Incorporation provide, among other things, for indemnification and limitations to the liability of the Company’s officers and directors. As a result of the reverse stock split, which became effective on December 4, 2013, every 113 shares of the Company’s outstanding common stock prior to the effect of that amendment was combined and reclassified into one share of the Company’s common stock, and the number of outstanding shares of the Company’s common stock was reduced from 1,292,103,309 to 11,434,611 shares. All share, stock option and per share information in these consolidated financial statements have been adjusted to reflect the stock split on a retroactive basis.

WARRANTS, DEBENTURES AND NOTES

WARRANTS, DEBENTURES AND NOTES	3 Months Ended	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2016	Sep. 30, 2015
Debt Disclosure [Abstract]
WARRANTS, DEBENTURES AND NOTES	NOTE 9 – DEBENTURES AND NOTES: Senior Debentures offering Beginning in November 2015, the Company conducted an offering (the “Offering”) of up to $3,000,000 of the Company’s Senior Debentures (the “Debentures”) and Warrants (the “Warrants”, together with the “Debentures”, the “Securities”) to purchase up to 8,000,000 shares of common stock of the Company, par value $0.001 per share, in proportion pro rata to each Subscriber’s subscription amount relative to the total Offering amount, with 50% of the shares exercisable at a price per share of $0.05 and the other 50% of the shares exercisable at price per share of $0.075. The Debentures bear interest at 11%, paid quarterly, and mature in two years. The Debentures are secured by a pledge agreement between the Company and each investor, whereby the Company pledged as collateral up to 49% of its shares of common stock in Eastern Sphere, Ltd., our wholly-owned subsidiary (the “Pledge Agreement”). The Pledge Agreement further provides that the Company’s obligations under the Debentures rank senior to all other indebtedness of Blue Sphere Corporation, but are subordinate to all indebtedness and liabilities of its subsidiaries and project-level operating entities. The Warrants are exercisable for 5 years from the date of issuance, with 50% exercisable at $0.05 per share and 50% exercisable at $0.075 per share The warrants were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $208,597 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 Risk-free interest rate 1.74 % Expected term (years) 5 Volatility 202 % The Securities were offered pursuant to subscription agreements with each investor (the “Subscription Agreement”). Pursuant to the Subscription Agreements, the investors in the Offering shall have the right to collectively designate one observer or member to the Company’s Board of Directors. On December 23, 2015, the Company completed the closing of the Offering and entered into Subscription Agreements with investors representing aggregate gross proceeds to the Company of $3,000,000. The Company engaged Maxim Group LLC (“Maxim”) to assist in the Offering. Pursuant to the terms of an engagement letter between Maxim and the Company, Maxim received commissions equal to 7% of the gross proceeds raised by Maxim in the Offering, as well as common stock purchase warrants for a number of securities equal to 8% of the total amount of securities sold in the Offering, at a price per share equal to 110% of the price of the securities paid by investors in the Offering. Based on the agreement the Company granted Maxim 4,480,000 warrants at an average exercise price of $ 0.6875.	NOTE 9 – WARRANTS, DEBENTURES AND NOTES On February 3, 2016, the Company issued 3-year warrants to purchase up to 1,500,000 shares of Company’s common stock at an exercise price of $0.06 per share, in full satisfaction of certain obligations of the Company. The Company has estimated the fair value of such warrants at a value of $87,331 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 Risk-free interest rate 1.2 % Expected term (years) 3 Volatility 203 % Changes in the fair value of the warrants are recorded as interest expenses. Senior Debentures Offering Beginning in November 2015, the Company conducted an offering (the “Debenture Offering”) of up to $3,000,000 of the Company’s Senior Debentures (the “Debentures”) and warrants (the “Debenture Offering Warrants”, together with the “Debentures”, the “Debenture Offering Securities”) to purchase up to 8,000,000 shares of Common Stock in proportion to each Subscriber’s subscription amount relative to the total offering amount, with 50% of the Debenture Offering Warrants exercisable at a price per share of $0.05 and the other 50% of the Debenture Offering Warrants exercisable at price per share of $0.075. The Debentures bear interest at 11%, paid quarterly, and mature in two years. The Debentures are secured by a pledge agreement between the Company and each investor, whereby the Company pledged as collateral up to 49% of its shares of common stock in Eastern Sphere, Ltd., our wholly-owned subsidiary (the “Pledge Agreement”). The Pledge Agreement further provides that the Company’s obligations under the Debentures rank senior to all other indebtedness of Blue Sphere Corporation, but are subordinate to all indebtedness and liabilities of its subsidiaries and project-level operating entities. The Debenture Offering Warrants are exercisable for 5 years from the date of issuance, with 50% exercisable at $0.05 per share and 50% exercisable at $0.075 per share The November 2015 Warrants were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $208,597 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 Risk-free interest rate 1.74 % Expected term (years) 5 Volatility 202 % The Debenture Offering Securities were offered pursuant to subscription agreements with each investor (the “Debenture Offering Subscription Agreement”). Pursuant to the Debenture Offering Subscription Agreements, the investors in the Debenture Offering shall have the right to collectively designate one observer or member to the Company’s Board of Directors. On December 23, 2015, the Company completed the closing of the Debenture Offering and entered into Debenture Offering Subscription Agreements with investors representing aggregate gross proceeds to the Company of $3,000,000. The Company engaged Maxim Group LLC to assist in the Debenture Offering. Pursuant to the terms of an engagement letter between Maxim and the Company, Maxim received commissions equal to 7% of the gross proceeds raised by Maxim in the Debenture Offering and warrants to purchase, in the aggregate, up to 4,480,000 shares of Common Stock at an exercise price of $0.06875 per share. The Company has estimated the fair value of such warrants at a value of $116,599 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 Risk-free interest rate 1.74 % Expected term (years) 5 Volatility 202 %	NOTE 4 – DEBENTURES, NOTES AND LOANS Convertible Promissory Notes Between August 4, 2014 and September 30, 2014, the Company issued convertible promissory notes (the “Notes”) to accredited investors in an aggregate principal amount of $1,408,150 for an aggregate purchase price of $1,201,414, net of expenses incurred in connection of such notes. Between October 1, 2014 and January 20, 2015, the Company issued convertible promissory notes (the “Notes”) to accredited investors in an aggregate principal amount of $504,250 for an aggregate purchase price of $464,970, net of expenses incurred in connection of such notes. The Notes were generally mature one-year from the date of issuance and accrue interest at rates ranging from 8% to 18% per annum and in an event of default, the Notes bear interest at rates ranging from 12% to 24% per annum. The Notes may generally be converted into shares of the Company’s common stock at conversion prices ranging from 37% to 45% discounts to lowest trade or closing prices during periods in proximity to the time of conversion subject to further discounts in the case of certain events of default. In accordance with ASC 470-20, the Company allocated to additional paid-in capital a portion of the proceeds of the notes equal to the intrinsic value of the beneficial conversion feature embedded in the debentures and recorded a corresponding discount on such debentures. The amounts allocated to additional paid-in capital were $1,040,919 and $482,485 as of September 30, 2014 and September 30, 2015, respectively. As of September 30, 2015 the notes were converted or repaid in full. During the year ended September 30, 2015, the Company recorded amortization expenses in the amounts of $1,523,404, in respect of the discounts recorded on the debentures. From February through September 2015, convertible promissory notes holders representing an aggregate principal amount of $1,480,716 converted their notes into 75,060,414 shares of the Company’s common stock. The Notes include customary default provisions related to payment of principal and interest and bankruptcy or creditor assignment. In addition, it shall constitute an event of default under certain of the Notes if the Company is delinquent in its filings with the Securities and Exchange Commission, ceases to be quoted on the OTCQB, its common stock is not DWAC eligible or if it has to restate its financial statements in any material respect. In the event of an event of default the Notes may become immediately due and payable at premiums to the outstanding principal. The Notes also provide that if shares issuable upon conversion of the Notes are not timely delivered in accordance with the terms of the Notes then the Company shall be subject to certain cash or share penalties that increase proportionally to the duration of the delinquency up to certain maximums. The Company paid aggregate commissions of $7,500 to MD Global Partners, LLC and $46,000 to Carter Terry & Company (“Carter Terry”), registered broker-dealers, in connection with the issuance of some of Notes in the aggregate principal of up to $480,000. In addition, Carter Terry is entitled to receive 100,000 shares of the Company’s common stock and a further amount of shares of the Company’s common stock equal to 4% of capital raised by them divided by the closing price of the Company common stock on the date of close. On December 8, 2014 the Company issued 209,041 shares of the Company’s common stock, see note 6 below. Loans On March 7, 2012, the Company entered into a loan agreement with Eli Weinberg, pursuant to which Mr. Weinberg loaned the Company $135,000. The full principal amount of the loan remains outstanding. Mr. Weinberg has the option to convert any or all of the principal amount of the loan to common stock of the Company. On March 15, 2015, the Company entered into a loan agreement with Ori Ackerman (the “Ackerman Loan Agreement”), pursuant to which the Company agreed to borrow $220,000 and issue 3,000,000 shares to Ori Ackerman. The Company received $200,000 under the Ackerman Loan Agreement, as $20,000 was deducted from the original amount of the loan and considered payment of interest in advance. The loan bears no additional interest, and is payable in full within three business days of the date the Company receives revenue from any of its Charlotte, Rhode Island or Italian projects. The Company’s obligations under the loan are personally guaranteed by Shlomi Palas, the Company’s Chief Executive Officer. On March 25, 2015, the Company entered into a loan agreement with Valter Team, Ltd. (the “Valter Team Loan Agreement”), pursuant to which the Company agreed to borrow $68,750 and issue 250,000 shares to Valter Team Ltd. The Company received $62,500 under the Valter Team Loan Agreement, as $6,250 was deducted from the original amount of the loan. This loan bears no interest and is payable in full on the earlier of the date the Company receives cash proceeds from any of its Charlotte, Rhode Island or Italian projects and December 25, 2015. The Company’s obligations under the loan are personally guaranteed by Shlomi Palas, the Company’s Chief Executive Officer. As of September 30, 2015, the Company repaid the loan in full and issued the 250,000 shares.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2016	Sep. 30, 2015
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10 – SUBSEQUENT EVENTS: On January 26, 2016 the Company issued 1,000,000 shares of common stock of the Company to a consultant in consideration for financial consulting services. In February 2016, the Company conducted an offering (the “Offering”) consisting of (a) up to USD $1,925,000 of the Company's shares of common stock, par value $0.001 per share (“Common Stock”), priced at the closing price for shares of Common Stock, as reported on the OTCQB Venture Marketplace, on the trading day prior to the closing of the Offering, and (b) 5-year warrants to purchase shares of Common Stock in an amount equal to 50% of the number of shares of Common Stock so purchased by the subscriber (the “Warrants”, together with the shares of Common Stock subscribed for, the “Securities”). The Securities have been offered pursuant to subscription agreements with each investor (the “Subscription Agreement”). In addition to other customary provisions, each Subscription Agreement provides that the Company will use its reasonable commercial efforts to register all shares of Common Stock sold in the Offering, including all shares of Common Stock underlying the Warrants, within 60 days of the closing of the Offering. The Warrants are exercisable for 5 years from the date of issuance at $0.10 per share, include an option by which the holder may exercise the Warrant by means of a cashless exercise, and include customary weighted-average price adjustment and anti-dilution terms. On February 15, 2016, the Company completed the only closing of the Offering, representing aggregate gross proceeds to the Company of USD $1,925,000. In connection with the closing, the Company and subscribers entered into (a) Subscription Agreements for, in the aggregate, 35,000,000 shares of Common Stock at $0.055 per share, and (b) Warrants to purchase, in the aggregate, up to 17,500,000 shares of Common Stock at an exercise price of $0.10 per share. The Company engaged Maxim to assist in the Offering. Pursuant to the terms of an engagement letter between Maxim and the Company, Maxim received commissions equal to 7% of the gross proceeds raised by Maxim in the Offering, as well as common stock purchase warrants for a number of securities equal to 8% of the total amount of securities sold in the Offering, at a price per share equal to 110% of the price of the securities paid by investors in the Offering.	NOTE 10 – SUBSEQUENT EVENTS In June and July 2016, we conducted an offering (the “June Offering”) consisting of (a) up to USD $3,000,000 of our shares of Common Stock, priced at the closing price for shares of Common Stock, as reported on the OTCQB Venture Marketplace on the trading day prior to each respective closing of the June Offering, and (b) five-year warrants (the “June Warrants”, together with the shares of Common Stock subscribed for, the “June Securities”) to purchase shares of Common Stock in an amount equal to one hundred percent (100%) of the number of shares of Common Stock so purchased by the subscriber, with an exercise price equal to the per share price of the Common Stock or $0.011 per share, whichever is greater. The June Offering consisted of one or more closings, with the last closing to occur on or before July 26, 2016, or as extended by the Company in is sole discretion. The June Securities were offered pursuant to subscription agreements with each subscriber (the “June Subscription Agreement”). In addition to other customary provisions, each June Subscription Agreement provides that the Company will use its reasonable commercial efforts to register all shares of Common Stock sold in the June Offering, including all shares of Common Stock underlying the June Warrants, within twenty (20) days of the final closing of the June Offering. Each June Subscription Agreement also provides that if, during the period beginning on the date of the first closing of the June Offering and ending on the six month anniversary thereof, the Company completes (a) a subsequent closing of the June Offering or (b) a public or private offering and sale of USD $1,000,000 or more of Common Stock or warrants to purchase Common Stock, where such subsequent closing or offering, as applicable, provides for material deal terms and conditions more favorable than are contained in such June Subscription Agreement, then the June Subscription Agreement will be deemed modified to provide the applicable subscriber with the more favorable deal terms and conditions, and the Company will take all reasonable steps necessary to amend the June Securities and/or issue new securities to the applicable subscriber reflecting such more favorable material deal terms and conditions (the “June MFN Rights”). The June Warrants are exercisable for five years from the date of issuance, include an option by which the holder may exercise the June Warrant by means of a cashless exercise, and include customary weighted-average price adjustment and anti-dilution terms. On July 26, 2016, the Company completed closings of the June Offering, both such closings representing aggregate gross proceeds to the Company of USD $1,370,000. In connection with both closings, the Company and subscribers entered into (a) June Subscription Agreements for 18,266,668 shares of Common Stock at $0.075 per share, and (b) June Warrants to purchase up to 18,266,668 shares of Common Stock at an exercise price of $0.11 per share. The subscriber in the July 7, 2016 closing received an adjustment to its June Securities pursuant to its June MFN Rights. The June Offering ended on July 26, 2016. The Company engaged Maxim Group LLC to assist in the June Offering. Pursuant to the terms of an engagement letter between Maxim and the Company, in connection with both closings, Maxim received commissions equal to 4.44% of the gross proceeds raised, warrants to purchase up to 928,000 shares of Common Stock at an exercise price of $0.0825 per share, and warrants to purchase up to 928,000 shares of Common Stock at an exercise price of $0.121 per share.	NOTE 11 – SUBSEQUENT EVENTS: On October 21, 2015 the Company issued 1,630,000 and 8,484,848 shares of common stock of the Company in respect of the April Borenstein Subscription Agreement and June Borenstein Subscription Agreement, respectively. Italy Projects In September 2014, the Company entered into a letter of intent to acquire Kinexia S.p.A.’s right, interest and title in, to and under four biogas projects in the Vigevano area in Italy. The letter of intent also provides for the purchase of three additional biogas projects in the Emillia-Romagna and Lazio regions upon the same principals set forth in the letter of intent and subject to definitive agreements. After balance sheet date, on December 14, 2015, and pursuant to a Share Purchase Agreement, dated May 14, 2015 ( the “Share Purchase Agreement”), by and among the Company’s indirect wholly-owned subsidiary, Bluesphere Pavia (formerly called Bluesphere Italy S.r.l.) Pursuant to the Share Purchase Agreement, the Company paid an aggregate purchase price of $5,837,308 (€5,200,000) (the “Purchase Price”), subject to certain post-closing adjustments, to acquire the share capital of the SPVs. Fifty percent (50%) of the Purchase Price, adjusted for certain closing costs, was paid at closing, and the balance is due to the Sellers on the third anniversary of the closing date. The portion of the Purchase Price paid at closing was primarily financed by a loan of $3,255,422 (€2,900,000) pursuant to a Long Term Mezzanine Loan Agreement, dated August 18, 2015 (the “Loan Agreement”), by and among the Company, its wholly-owned subsidiary, Eastern Sphere Ltd. (“Eastern Sphere”), Eastern Sphere’s wholly-owned subsidiary, Bluesphere Italy, and Helios Italy Bio-Gas 1 L.P. On August 18, 2015, the Company and two of its wholly-owned subsidiaries, Eastern Sphere Ltd. (“Eastern Sphere”) and BlueSphere Italy, entered into a Long Term Mezzanine Loan Agreement (the “Helios Loan Agreement”) with Helios Italy Bio-Gas 1 L.P. (“Helios”). Under the Helios Loan Agreement, Helios will make up to $5,612,796 (€5,000,000) available to Bluesphere Pavia (the “Helios Loan”) to finance (a) ninety percent (90%) of the total required investment of the first four SVPs acquired, (b) eighty percent (80%) of the total required investment of up to three SVPs subsequently acquired, (c) certain broker fees incurred in connection with the acquisitions, and (d) any taxes associated with registration of an equity pledge agreement (as described below). Each financing of an SVP acquisition will be subject to specified conditions precedent and will constitute a separate loan under the Helios Loan Agreement. Helios may, within 90 days of a closing, require repayment of ten percent (10%) of the relevant loan and broker fees. If no such repayment is required, Helios may reduce the amount of its commitment to finance the acquisitions of the three additional SVPs to seventy to eighty percent (70-80%) of the total required investment. Helios’s commitment to provide any loan under the Helios Loan Agreement that is not utilized by June 30, 2016 will automatically cancel, unless extended in writing by Helios. Subject to specified terms, representations and warranties, the Helios Loan Agreement provides that each loan thereunder will accrue interest at a rate of 14.5% per annum, paid quarterly. Helios will also be entitled to an annual operation fee, paid quarterly. The final payment for each loan will become due no later than the earlier of (a) thirteen and one half years from the date such loan was made available to Bluesphere Italy, and (b) the date that the Feed in Tariff license granted to the relevant SVP expires. Pursuant to the Helios Loan Agreement and an equity pledge agreement, Eastern Sphere pledged all its shares in Bluesphere Pavia to secure all loan amounts utilized under the Helios Loan Agreement. The Company also entered into a no-interest bearing promissory note, dated December 8, 2015 (the “Palas Promissory Note”), with R.S. Palas Management Ltd. to finance a small portion of the Purchase Price. The Palas Promissory Note is for an amount of $132,462 (€118,000) and is due and payable, without interest or premium, on December 31, 2015. The payee under the Palas Promissory Note, R.S. Palas Management Ltd., is an entity owned and controlled by Shlomi Palas, the Company’s President and Chief Executive Officer and a member of its Board of Directors. In accordance with a Framework EBITDA Guarantee Agreement, dated July 17, 2015 (the “EBITDA Agreement”), between the Company and Austep S.p.A. (“Austep”), Austep will operate, maintain and supervise each biogas plant owned by the SPVs. In addition, Austep will guarantee a monthly aggregate EBITDA of $211,041 (€188,000) from the four SPVs for the initial six months following the acquisition, and thereafter Austep will guarantee an annual aggregate EBITDA of $4,220,823 (€3,760,000) from the four SPVs. Pursuant to the terms of the agreements with Austep, the Company will receive the guaranteed levels of EBITDA and Austep will receive any revenue in excess of these levels. Senior Debentures offering Beginning in November 2015, the Company conducted an offering (the “Offering”) of up to $3,000,000 of the Company's Senior Debentures (the “Debentures”) and Warrants (the “Warrants”, together with the “Debentures”, the “Securities”) to purchase up to 8,000,000 shares of common stock of the Company, par value $0.001 per share, in proportion pro rata to each Subscriber’s subscription amount relative to the total Offering amount, with 50% of the shares exercisable at a price per share of $0.05 and the other 50% of the shares exercisable at price per share of $0.075. The Debentures will bear interest at 11%, paid quarterly, and will mature in two years. The Debentures are secured by a pledge agreement between the Company and each investor, whereby the Company pledged as collateral up to 49% of its shares of common stock in Eastern Sphere, Ltd., our wholly-owned subsidiary (the “Pledge Agreement”). The Pledge Agreement further provides that the Company's obligations under the Debentures rank senior to all other indebtedness of Blue Sphere Corporation, but are subordinate to all indebtedness and liabilities of its subsidiaries and project-level operating entities. The Warrants are exercisable for 5 years from the date of issuance, with 50% exercisable at $0.05 per share and 50% exercisable at $0.075 per share The Securities are being offered pursuant to subscription agreements with each investor (the “Subscription Agreement”). Pursuant to the Subscription Agreements, the investors in the Offering shall have the right to collectively designate one observer or member to the Company’s Board of Directors. On December 23, 2015, the Company completed the only closing of the Offering and entered into Subscription Agreements with investors representing aggregate gross proceeds to the Company of $3,000,000. The Company engaged Maxim Group LLC (“Maxim”) to assist in the Offering. Pursuant to the terms of an engagement letter between Maxim and the Company, Maxim received commissions equal to 7% of the gross proceeds raised by Maxim in the Offering, as well as common stock purchase warrants for a number of securities equal to 8% of the total amount of securities sold in the Offering, at a price per share equal to 110% of the price of the securities paid by investors in the Offering.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Sep. 30, 2015
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS:	NOTE 5 – RELATED PARTY TRANSACTIONS On July 25, 2011, the Company, JLS and Roy Amitzur entered into a Management Services Agreement according to which JLS, and Mr. Amitzur are engaged to provide management services to the Company devoting at least 75% of this time to the Company, with Mr. Amitzur serving as Executive Vice President. The term of the agreement was originally for two years and in July 2013, was extended for a further eight months. Since the agreement expired in May 2014, Mr. Amitzur’s agreement was further extended on the same terms on an oral basis. For services rendered under the agreement, JLS is entitled to a monthly fee of US$10,000 + VAT subject to the Company raising an aggregate amount of at least $450,000. Subsequently, such fee increases to a monthly fee of $15,000 + VAT after the Company raises an aggregate equity investment of $2,000,000. Notwithstanding the raise of more than an aggregate of $2,000,000, payment of Mr. Amitzur monthly fee of US $10,000 + VAT has continued to-date. In addition, the Company issued to JLS 110,620 shares of common stock vesting in equal amounts quarterly over 24 months, all of which have fully vested. JLS and Mr. Amitzur are entitled to participate on similar terms as the other executives of the Company in bonus plans or incentive compensation plans for its employees. On February 29, 2012, the Company entered into an employment agreement with Mr. Palas to serve as the Company’s Chief Executive Officer for an indefinite term. This agreement was intended to extend the term of a previously entered into employment agreement with Mr. Palas whose term was expiring. Under the agreement, Mr. Palas receives monthly remuneration at a gross rate of USD$15,000 + VAT. Mr. Palas will be entitled to participate in any bonus plan or incentive compensation plan for its employees adopted by the Company. On November 5, 2012, the Board of Directors of the Company approved the issuance of 53,098 shares of the Company to its Chief Executive officer, 44,248 shares to the Chairman of the Board, 44,248 shares to the Executive Vice-President and 35,399 shares to the Chief Carbon Officer and general counsel of the Company. On March 18, 2013, the Board of Directors of the Company approved the issuance of 53,098 shares of the Company to its Chief Executive Officer, 44,248 shares to the Chairman of the Board, 44,248 shares to the Executive Vice-President and 35,399 shares to the Chief Carbon Officer and general counsel of the Company. On April 30, 2013, the Board of Directors of the Company approved the issuance of 230,089 shares of the Company and options to purchase 230,089 shares of common stock to its Chief Executive Officer, 203,540 shares and options to purchase 203,540 shares of common stock to the Chairman of the Board, 168,142 shares and options to purchase 168,142 shares of common stock to the Executive Vice-President and 88,496 shares and options to purchase 88,496 shares of common stock to both the Chief Carbon Officer and general counsel of the Company and for the CTO of Company. The shares and options will vest over a two year period with 1/8 of the total amount of the shares and options vesting at the end of each quarter from the date of the grant. On June 19, 2013 the Board of Directors of the Company approved the issuance of 53,098 shares of the Company to its Chief Executive officer, 44,248 shares to the Chairman of the Board, 44,248 shares to the Executive Vice-President and 35,399 shares to the Chief Carbon Officer and general counsel of the Company. On January 26, 2014, the Company signed a subscription agreement with Talya Levy-Tytiun (“Talya”) pursuant to which Talya agreed to invest an aggregate of $400,000 into the Company for the sale of 1,739,130 shares of common stock. The Company was obligated to issue Talya additional shares of the Company, if, six months from the date of the agreement her ownership in the Company would be reduced below 12.3%. In addition, the Company guaranteed that if on the first anniversary of the agreement, the share price of the Company common stock was 0.23$ per share or less, the Company shall transfer Talya such amount necessary to make Talya whole and reimburse her for any loss due to her investment. On September 17, 2014 the Company issued Talya 2,866,194, shares of common stock as a reimbursement under the above agreement. On December 13, 2013 the Board of Directors of the Company approved the issuance of 424,779 shares of the Company to its Chief Executive Officer, 353,982 shares to the Chairman of the Board, 353,982 shares to the Executive Vice-President and 283,186 shares to the Chief Carbon Officer and general counsel of the Company. Such shares were issued at January 9, 2014. On March 10, 2014 the Board of Directors of the Company approved the issuance of 250,000 shares of the Company to its Chief Executive Officer, 220,000 shares to the Chairman of the Board, 200,000 shares to the Executive Vice-President and 180,000 shares to the Chief Carbon Officer and general counsel of the Company. On May 27, 2014 the Company appointed Mr. Yigal Brosh as a member of the Board of Directors of the Company. Mr. Brosh was granted 200,000 options to purchase shares of common stock of the Company at an exercise price of $0.01 per share. The Options vets over a period of two years with a pro-rata portion vesting each three month period. On February 24, 2015, the Board of Directors approved a grant of up to 1,450,000 shares of common stock to certain of its directors under the 2010 Plan. In addition, on February 24, 2015 the Company granted under its 2014 Option Plan 7,450,000 shares of common stock and to 1,775,000 options to purchase shares of common stock to certain of its directors. The shares will vest on a quarterly basis over a two-year period, and the options will vest on a quarterly basis over a two-year period with an exercise price of $0.14 per share.

STOCK OPTIONS

STOCK OPTIONS	12 Months Ended
	Sep. 30, 2015
Stock Options
STOCK OPTIONS:	NOTE 7 – STOCK OPTIONS: The 2010 share option plan was established on March 3, 2010. On February 24, 2015, the Company’s Board of Directors approved and adopted the Global Share and Options Incentive Enhancement Plan (2014) (the “2014 Plan”), pursuant to which the Company may award shares of its common stock, options to purchase shares of its common stock and other equity-based awards to eligible participants. The 2014 Plan replaced the Company’s Global Share Incentive Plan (2010) (the “2010 Plan”). Subject to the terms and conditions of the 2014 Plan, the Board of Directors has full authority in its discretion, from time to time and at any time, to determine (i) eligible participants in the 2014 Plan, (ii) the number of options or shares to be covered by an award, (iii) the time or times at which an award shall be granted, (iv) the vesting schedule and other terms and conditions of an award, (v) the form(s) of written agreements applicable to an award, and (vi) any other matter which is necessary or desirable for, or incidental to, the administration of the 2014 Plan and the granting of awards thereunder. The 2014 Plan permits the grant of up to 13,100,000 shares of common stock and up to 3,175,000 options to purchase shares of common stock to certain of its managers, directors and key employees. The shares will vest on a quarterly basis over a two-year period, and the options will vest on a quarterly basis over a two-year period with an exercise price of $0.14 per share. Prior to approving the 2014 Plan, on February 24, 2015, the Board of Directors approved a grant of up to 2,575,000 shares of common stock to certain of its managers, directors and key employees under the 2010 Plan, of which 1,875,000 shares were issued as of September 30, 2015. The following table presents the Company’s stock option activity for employees and directors of the Company for the years ended September 30, 2013 through 2015: Number of Weighted Average Exercise Price Outstanding at September 30, 2012 778,761 0.5763 Granted — — Exercised — — Forfeited or expired — — Outstanding at September 30, 2013 778,761 0.5763 Granted 350,000 0.1770 Exercised — — Forfeited or expired — — Outstanding at September 30,2014 1,128,761 0.4530 Granted 3,175,000 0.1400 Exercised — — Forfeited or expired — — Outstanding at September 30,2015 4,303,761 0.2220 Number of options exercisable at September 30, 2015 1,847,511 0.3362 Number of options exercisable at September 30, 2014 684,071 0.5363 The fair value of the stock options granted in 2013 was estimated using the Black-Scholes option valuation model that used the following assumptions: % Dividend yield 0 Risk-free interest rate 0.32 % Expected term (years) 5 Volatility 390 % The fair value of the options granted above using the Black-Scholes model is $0.565 per option. The fair value of the stock options granted in 2014 was estimated using the Black-Scholes option valuation model that used the following assumptions: % Dividend yield 0 Risk-free interest rate 0.88 % Expected term (years) 3 Volatility 123%-157 % The fair value of the options granted above using the Black-Scholes model is between $0.190 to $0.214 per option. The fair value of the stock options granted in 2015 was estimated using the Black-Scholes option valuation model that used the following assumptions: % Dividend yield 0 Risk-free interest rate 1.47 % Expected term (years) 5 Volatility 147 % The fair value of the options granted above using the Black-Scholes model is $0.111 per option. Costs incurred in respect of stock based compensation for employees and directors, for the year ended September 30, 2015, 2014 and 2013 were $231, $1,711 and $203 thousands respectively. The following table summarizes information about options and warrants to employees, officers and directors outstanding at September 30, 2015 under the plans: Options and Warrants Outstanding Vested and Exercisable Exercise Price Number of Option Weighted Average Remaining Contractual Life (Years) Number of Option weighted Average Exercise Price 0.01 200,000 1.65 125,000 0.01 0.14 3,175,000 4.41 793,750 0.14 0.3 50,000 1.72 50,000 0.30 0.4 50,000 1.72 50,000 0.40 0.5 50,000 1.72 50,000 0.50 0.5763 778,761 2.58 778,761 0.5763 4,303,761 3.78 1,847,511 0.3362 As of September 30, 2015 the aggregated intrinsic value for the options vested and exercisable was $2.5 thousands with a weighted average remaining contractual life of 1.65 years. The unrecognized compensation expense calculated under the fair value method for the stock options expected to vest as of September 30, 2015 is $249,962 and is expected to be recognized over a weighted average period of 1.5 years. The weighted average grant date fair value of the options granted in 2015, 2014 and 2013 was $0.111, $0.192, $0.565 respectively.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Sep. 30, 2015
Income Taxes
INCOME TAXES:	NOTE 8 – INCOME TAXES: US resident companies are taxed on their worldwide income for corporate income tax purposes at a statutory rate of 35%. No further taxes are payable on this profit unless that profit is distributed. If certain conditions are met, income derived from foreign subsidiaries is tax exempt in the US under applicable tax treaties to avoid double taxation. Taxable income of Israeli companies is subject to tax at the rate of 25% in 2013, 26.5% in the year 2014 and 25% in the year 2015 and onwards. The Company accounts for income taxes using the liability method, which requires the determination of deferred tax assets and liabilities based on the differences between the financial and tax bases of assets and liabilities using enacted tax rates in effect for the year in which differences are expected to reverse. Deferred tax assets are adjusted by a valuation allowance, if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred income taxes reflect the net effects of temporary differences between the amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The breakdown of the deferred tax asset as of September 30 2015, 2014 and 2013 is as follows: 2015 2014 2013 U.S. dollars in thousands Deferred tax assets: Net operating loss carry-forward $ 6,331 $ 3,267 $ 2,502 Valuation allowance (6,331 ) (3,267 ) (2,502 ) $ 0 $ 0 $ 0 A valuation allowance is provided when it is more likely than not that some portion of the deferred tax asset will not be realized. Management has determined, based on its recurring net losses, lack of a commercially viable product and limitations under current tax rules, that a full valuation allowance is appropriate. U.S. dollars in thousands Valuation allowance, September 30, 2014 $ 3,267 Increase 3,064 Valuation allowance, September 30, 2015 $ 6,331 Carry forward losses of the Company are approximately $14,130 thousand at September 30, 2015 and available throughout 2035. Carry forward losses of the Israeli subsidiary are approximately $3,138 thousand at September 30, 2015 and have no expiration date. Reconciliation between the theoretical tax expense, assuming all income is taxed at the statutory tax rate applicable to income of the Company and the actual tax expense as reported in the Statement of Operations, is as follows: Year ended December 31, 2015 2014 2013 Loss before taxes, as reported in the consolidated statements of operations $ 7,462 $ 7,376 $ 1,970 Federal statutory rate 35 % 35 % 35 % Theoretical tax benefit on the above amount at federal statutory tax rate 2,612 2,582 690 Losses and other items for which a valuation allowance Was provided or benefit from loss carry forward (2,612 ) (2,582 ) (690 ) Actual tax expense — — —

NET LOSS PER SHARE DATA

NET LOSS PER SHARE DATA	12 Months Ended
	Sep. 30, 2015
Net Loss Per Share Data
NET LOSS PER SHARE DATA	NOTE 9 – NET LOSS PER SHARE DATA: The shares issuable upon the exercise of options, and conversion of convertible notes and warrants, which have been excluded from the diluted per share amounts because their effect would have been anti-dilutive, include the following: September 30, 2015 September 30, 2014 September 30, 2013 Options: weighted average number 1,847,511 684,071 194,690 weighted average exercise price $ 0.3362 $ 0.5363 $ 0.5763

OTHER LOSS (INCOMES)

OTHER LOSS (INCOMES)	12 Months Ended
	Sep. 30, 2015
Other Loss Incomes
OTHER LOSS (INCOMES)	NOTE 10 – OTHER LOSS (INCOMES) On January 31, 2012, the Company lent an Israeli company, CTG Clean Technology Group Limited (the “Borrower”), U.S. $30,000 at an annual rate of interest of eight percent (8%). The purpose of this loan was to provide the borrower capital to continue its operations while the Company considered acquiring such company. On February 8, 2012, the Company received the cash to make such loan to the borrower from a Cyprus company (JLS Investment Holding). As of December 30, 2012 such loan had been written-off in whole. In May 2015, CTG had repaid the loan in full and the company recorded incomes in the amount of $38 thousands.

SIGNIFICANT ACCOUNTING POLICI23

SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2016	Sep. 30, 2015
Accounting Policies [Abstract]
Functional currency			a. Functional currency The currency of the primary economic environment in which the operations of the Company are conducted is the U.S dollar (“$” or “dollar”). Most of the Company’s expenses are incurred in dollars. Most of the Company’s external financing is in dollars. The Company holds most of its cash and cash equivalents in dollars. Thus, the functional currency of the Company is the dollar. Since the dollar is the primary currency in the economic environment in which the Company operates, monetary accounts maintained in currencies other than the dollar are re-measured using the representative foreign exchange rate at the balance sheet date. Operational accounts and non-monetary balance sheet accounts are measured and recorded at the rate in effect at the date of transaction. The effects of foreign currency re-measurement are reported in current operations (as “financial expenses - net) and have not been material to date.
Principles of consolidation			b. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Inter-company balances and transactions have been eliminated upon consolidation.
Cash equivalents			c. Cash equivalents are short-term highly liquid investments which include short term bank deposit (up to three months from date of deposit), that are not restricted as to withdrawals or use that are readily convertible to cash with maturities of three months or less as of the date acquired.
Property, plant and equipment			d. Property, plant and equipment are stated at cost, less accumulated depreciation. Assets are depreciated using the straight-line method over their estimated useful lives. Computers, software and electronic equipment are depreciated over three years. Tools and equipment are depreciated over five years. Furniture is depreciated over fourteen years.
Investment in affiliated companies			e. Investments in affiliated companies that are not controlled but over which the Company can exercise significant influence (generally, entities in which the Company holds approximately between 20% to 50% of the voting rights of the investee) are presented using the equity method of accounting. Profits on intercompany sales, not realized outside the Company, are eliminated. The Company discontinues applying the equity method when its investment (including advances and loans) is reduced to zero and the Company has not guaranteed obligations of the affiliate or otherwise committed to provide further financial support to the affiliate. Investments in preferred shares, which are not in substance common stock, are recorded on a cost basis according to ASC 323-10-15-13, “Investments - Equity Method and Joint Ventures - In-substance Common Stock” and ASC 323-10-40-1, "Investment -Equity Method and Joint Ventures - Investee Capital Transactions". A change in the Company’s proportionate share of an investee’s equity, resulting from issuance of common or in-substance common shares by the investee to third parties, is recorded as a gain or loss in the consolidated income statements in accordance with ASC 323-10-40-1. Investments in non-marketable equity securities of entities in which the Company does not have control or the ability to exercise significant influence over their operation and financial policies, are recorded at cost (generally when the Company holds less than 20% of the voting rights). Management evaluates investments in affiliated companies, partnerships and other non-marketable equity securities for evidence of other-than-temporary declines in value. Such evaluation is dependent on the specific facts and circumstances. Accordingly, in determining whether other-than-temporary declines exist, management evaluates various indicators for other-than-temporary declines and evaluates financial information (e.g. budgets, business plans, financial statements, etc.). During 2015 and 2014, no material impairment was recognized.
Use of estimates			e. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results may differ from those estimates.
Share-base payments			f. Share-based payments to employees are measured at the fair value of the options issued and amortized over the vesting periods. Share-based payments to non-employees are measured at the fair value of the goods or services received or the fair value of the equity instruments issued if it is determined the fair value of the goods or services cannot be reliably measured, and are recorded at the date the goods or services are received. The amount recognized as an expense is adjusted to reflect the number of awards expected to vest. The offset to the recorded cost is to share-based payments reserve. Consideration received on the exercise of stock options is recorded as capital stock and the related share-based payments reserve is transferred to share capital.
Loss per share			g. Loss per share Net loss per share, basic and diluted, is computed on the basis of the net loss for the period divided by the weighted average number of common shares outstanding during the period. Diluted net loss per share is based upon the weighted average number of common shares and of common shares equivalents outstanding when dilutive. Common share equivalents include: (i) outstanding stock options under the Company’s share incentive plan and warrants which are included under the treasury share method when dilutive, and (ii) common shares to be issued under the assumed conversion of the Company’s outstanding convertible notes, which are included under the if-converted method when dilutive. The computation of diluted net loss per share for the years ended September 30, 2015, 2014, and 2013, does not include common share equivalents, since such inclusion would be anti-dilutive.
Deferred income taxes			h. Deferred taxes are determined utilizing the asset and liability method based on the estimated future tax effects of differences between the financial accounting and tax bases of assets and liabilities under the applicable tax laws. Deferred tax balances are computed using the tax rates expected to be in effect when those differences reverse. A valuation allowance in respect of deferred tax assets is provided if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company has provided a full valuation allowance with respect to its deferred tax assets.
Comprehensive loss			i. The Company has no component of comprehensive income loss other than net loss.
Revenue recognition	d. Revenue recognition Revenues related to the sale of electricity are recorded based upon output delivered and capacity provided at rates specified under relevant contract terms.	d. Revenue recognition Revenues related to the sale of electricity are recorded based upon output delivered and capacity provided at rates specified under relevant contract terms.	k. The Company recognizes revenues from services rendered in accordance with ASC Topic 605-20 Revenue Recognition from Services. The Company records services to be supplied under contractual agreements as deferred revenue until such related services are provided.
Business Combinations and Goodwill	a. Business combinations and Goodwill The Company accounts for its business combinations using the purchase method of accounting. Under this method, the Company allocates the purchase price to tangible and intangible assets acquired and liabilities assumed based on estimated fair values at the date of acquisition, with the excess of the purchase price amount being allocated to goodwill. Acquisition-related and integration costs associated to the business combination are expensed as incurred. Changes in estimates associated with future income tax assets after measurement period are recognized as income tax expense with prospective application to all business combinations regardless of the date of acquisition. Goodwill for each reporting unit is assessed for impairment at least annually, or when an event or circumstance occurs that more likely than not reduces the fair value of a reporting unit below its carrying amount. An impairment charge is recorded when the carrying amount of the reporting unit exceeds its fair value and is determined as the difference between the goodwill’s carrying amount and its implied fair value.	a. Business combinations and Goodwill The Company accounts for its business combinations using the purchase method of accounting. Under this method, the Company allocates the purchase price to tangible and intangible assets acquired and liabilities assumed based on estimated fair values at the date of acquisition, with the excess of the purchase price amount being allocated to goodwill. Acquisition-related and integration costs associated to the business combination are expensed as incurred. Changes in estimates associated with future income tax assets after measurement period are recognized as income tax expense with prospective application to all business combinations regardless of the date of acquisition. Goodwill for each reporting unit is assessed for impairment at least annually, or when an event or circumstance occurs that more likely than not reduces the fair value of a reporting unit below its carrying amount. An impairment charge is recorded when the carrying amount of the reporting unit exceeds its fair value and is determined as the difference between the goodwill’s carrying amount and its implied fair value. Goodwill consists of allocated acquisition costs of PPAs, which are amortized using the straight-line method over the 15 year terms of the agreements (see Note 3).
Intangible Assets	b. Intangible Assets Intangible assets consist of allocated acquisition costs of power purchase agreements, which are amortized using the straight-line method over the 15 year terms of the agreements (see Note 3).	b. Intangible Assets Intangible assets consist of non-monetary and separately identifiable assets, which can be controlled and are expected to generate future economic benefits. Such assets are recognized at acquisition and/or production cost, including directly attributable expenses to make the asset ready for use, net of accumulated amortization charges and any impairment losses. The costs incurred internally to develop new services and platforms are considered intangible assets generated internally and are recognized as assets only if the following requirements are met: 1. the cost incurred for the development of the assets can be reliably measured; 2. the entity has the intention, the availability of financial resources, the ability to complete the assets and to use or sell them; 3. the entity has the intention, the availability of financial resources, the ability to complete the assets and to use or sell them; Capitalized development costs include only expenses incurred that can be directly attributed to the process of developing new products and services. Intangible assets with a finite useful life are amortized on a straight-line basis over their useful lives and are tested for impairment when circumstances indicate that the carrying value may be impaired. The amortization period and the amortization method for intangible assets with a finite useful lives are reviewed at least at each reporting date. Changes in expected useful lives, or in the way the future economic benefits will be generated by the assets, are either recognized through a change in the period or in the amortization method and are accounted for as changes in accounting estimates. The amortization charges for intangible assets with a finite useful life are classified in the statement of income, in the costs appropriate for the function of the related intangible assets.
Long-Lived Assets	c. Long-Lived Assets When events or changes in circumstances indicate that the carrying amount of long-lived assets, such as capital assets and intangible assets, may not be recoverable, undiscounted estimated cash flows are projected over their remaining term and compared to the carrying amount. To the extent that such projections indicate that future undiscounted cash flows are not sufficient to recover the carrying amounts of related assets, a charge is recorded to reduce the carrying amount to the projected future discounted cash flows.	c. Long-Lived Assets When events or changes in circumstances indicate that the carrying amount of long-lived assets, such as capital assets and intangible assets, may not be recoverable, undiscounted estimated cash flows are projected over their remaining term and compared to the carrying amount. To the extent that such projections indicate that future undiscounted cash flows are not sufficient to recover the carrying amounts of related assets, a charge is recorded to reduce the carrying amount to the projected future discounted cash flows.
Newly issued accounting pronouncements			l. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Accounting Standards Codification (“ASC”) 605, Revenue Recognition. The new revenue recognition standard requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. In August 2015, the FASB issued Accounting Standards Update No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, or ASU 2015-14. This amendment defers the effective date of the previously issued Accounting Standards Update ASU 2014-09, until the interim and annual reporting periods beginning after December 15, 2017. Earlier application is permitted for interim and annual reporting periods beginning after December 15, 2016. If the Company begins generating revenue prior to the effective date of ASU 2015-14, the Company will evaluate the effect that ASU 2014-09 will have on the results of operations and financial position. In August 2015, the FASB has issued Accounting Standards Update (ASU) No. 2015-15, Interest - Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements - Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting . This ASU adds SEC paragraphs pursuant to the SEC Staff Announcement at the June 18, 2015, Emerging Issues Task Force meeting about the presentation and subsequent measurement of debt issuance costs associated with line-of-credit arrangements. Given the absence of authoritative guidance within ASU 2015-03 for debt issuance costs related to line-of-credit arrangements, the SEC staff would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. The Company does not expect this update will have a material impact on the presentation of the Company’s consolidated financial position, results of operations and cash flows. In September 2015, the FASB issued ASU 2015-16, Business Combinations (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments, which eliminates the requirement to retrospectively account for changes to provisional amounts initially recorded in a business acquisition opening balance sheet. Prior to the issuance of ASU 2015-16, an acquirer was required to restate prior period financial statements as of the acquisition date for adjustments to provisional amounts. This guidance is effective for fiscal years beginning after December 15, 2015, including interim periods within fiscal years. The Company is evaluating the effect, if any, this update will have on the Company’s consolidated financial position, results of operations and cash flows. In November 2015, the FASB has issued Accounting Standards Update (ASU) No. 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes, which changes how deferred taxes are classified on organizations’ balance sheets. The ASU eliminates the current requirement for organizations to present deferred tax liabilities and assets as current and noncurrent in a classified balance sheet. Instead, organizations will be required to classify all deferred tax assets and liabilities as noncurrent. The amendments apply to all organizations that present a classified balance sheet. For public companies, the amendments are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company does not expect this update will have a material impact on the presentation of the Company’s consolidated financial position, results of operations and cash flows.

COMMON SHARES (Tables)

COMMON SHARES (Tables)	6 Months Ended
	Jun. 30, 2016
Stockholders' Equity Note [Abstract]
Schedule of assumptions in the Black-Scholes warrant pricing model	The Company has estimated the fair value of such warrants at a value of $933,358 at the date of issuance and using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 Risk-free interest rate 1.20 % Expected term (years) 5 Volatility 203 % The Company has estimated the fair value of such warrants at a value of $224,413 at the date of issuance and using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 Risk-free interest rate 1.20 % Expected term (years) 5 Volatility 203 %

WARRANTS, DEBENTURES AND NOTES

WARRANTS, DEBENTURES AND NOTES (Tables)	3 Months Ended	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2016	Sep. 30, 2015
Debt Disclosure [Abstract]
Schedule of assumptions used for fair value of derivative liabilities	The Company has estimated the fair value of such warrants at a value of $208,597 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 Risk-free interest rate 1.74 % Expected term (years) 5 Volatility 202 %	The Company has estimated the fair value of such warrants at a value of $87,331 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 Risk-free interest rate 1.2 % Expected term (years) 3 Volatility 203 % The Company has estimated the fair value of such warrants at a value of $208,597 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 Risk-free interest rate 1.74 % Expected term (years) 5 Volatility 202 % The Company has estimated the fair value of such warrants at a value of $116,599 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 Risk-free interest rate 1.74 % Expected term (years) 5 Volatility 202 %	NOTE 1 – GENERAL a. Blue Sphere Corp. (“the Company”), together with its wholly-owned subsidiaries, Eastern Sphere Ltd. (“Eastern”), Binosphere Inc (“Binosphere”), Johnstonsphere LLC (“Johnstonsphere”), and Sustainable Energy Ltd. (“SEL”), is focused on project integration in the clean energy production and waste to energy markets. As of September 30, 2015, Tipping LLC and Charlottesphere LLC, two former subsidiaries of the Company, had been dissolved and Johnstonsphere had not commenced operations. On May 12, 2015 the Company formed Bluesphere Pavia (formerly called Bluesphere Italy S.r.l.), a subsidiary of Eastern in order to acquire certain biogas plants located in Italy (see note 2 below). The Company was incorporated in the state of Nevada on July 17, 2007 and was originally in the business of developing and promoting automotive internet sites. On February 17, 2010, the Company conducted a reverse merger, name change and forward split of its common stock, and in March 2010 current management took over operations, at which point the Company changed its business focus to become a project integrator in the clean energy production and waste to energy markets. On October 2, 2014, the Company, together with certain third parties, established Permanent Energy Ltd (“Permanent Energy”) in Israel. Permanent Energy was focused on Build-Own-Operate projects and project integration in the clean energy production and waste to energy markets, primarily in Israel. The Company held a 50% interest in Permanent Energy. Permanent Energy ceased its operations in February 2015 and is in the process of dissolution. The Company is currently focusing on (i) 10 projects related to the construction, acquisition or development of biogas facilities and (ii) a recently licensed fast charging battery technology. On November 26, 2013, the Company amended and restated its Articles of Incorporation to authorize the issuance of 500,000,000 shares of preferred stock, $0.001 par value, in one or more series and with such rights, preferences and privileges as its Board of Directors may determine and to effect a 1 for 113 reverse stock split of the Company’s outstanding common stock. In addition, the Amended and Restated Articles of Incorporation provide, among other things, for indemnification and limitations to the liability of the Company’s officers and directors. As a result of the reverse stock split, which became effective on December 4, 2013, every 113 shares of the Company’s outstanding common stock prior to the effect of that amendment was combined and reclassified into one share of the Company’s common stock, and the number of outstanding shares of the Company’s common stock was reduced from 1,292,103,309 to 11,434,611 shares. All share, stock option and per share information in these consolidated financial statements have been adjusted to reflect the stock split on a retroactive basis. b. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As of September 30, 2015, the Company had approximately $161 thousand in cash, a negative working capital of approximately $7,542 thousand, a stockholders’ deficiency of approximately $2,694 thousand and an accumulated deficit of approximately $43,404 thousand. Management anticipates their business will require substantial additional investments that have not yet been secured. The Company anticipates that the existing cash will not be sufficient to continue its operations through the next 12 months. Management is continuing in the process of fund raising in the private equity markets as the Company will need to finance future activities and general and administrative expenses. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Company’s ability to continue as a going concern is dependent upon raising capital from financing transactions and revenue from operations. These financial statements do not include any adjustments that may be necessary should the Company be unable to continue as a going concern. The Company’s continuation as a going concern is dependent on its ability to obtain additional financing as may be required and ultimately to attain profitability.

STOCK OPTIONS (Tables)

STOCK OPTIONS (Tables)	12 Months Ended
	Sep. 30, 2015
Stock Options Tables
Schedule of stock option activity for employees and directors	The following table presents the Company’s stock option activity for employees and directors of the Company for the years ended September 30, 2013 through 2015: Number of Weighted Average Exercise Price Outstanding at September 30, 2012 778,761 0.5763 Granted — — Exercised — — Forfeited or expired — — Outstanding at September 30, 2013 778,761 0.5763 Granted 350,000 0.1770 Exercised — — Forfeited or expired — — Outstanding at September 30,2014 1,128,761 0.4530 Granted 3,175,000 0.1400 Exercised — — Forfeited or expired — — Outstanding at September 30,2015 4,303,761 0.2220 Number of options exercisable at September 30, 2015 1,847,511 0.3362 Number of options exercisable at September 30, 2014 684,071 0.5363
Schedule of fair value of the stock options granted Black-Scholes option valuation model	The fair value of the stock options granted in 2013 was estimated using the Black-Scholes option valuation model that used the following assumptions: % Dividend yield 0 Risk-free interest rate 0.32 % Expected term (years) 5 Volatility 390 % The fair value of the stock options granted in 2014 was estimated using the Black-Scholes option valuation model that used the following assumptions: % Dividend yield 0 Risk-free interest rate 0.88 % Expected term (years) 3 Volatility 123%-157 % The fair value of the stock options granted in 2015 was estimated using the Black-Scholes option valuation model that used the following assumptions: % Dividend yield 0 Risk-free interest rate 1.47 % Expected term (years) 5 Volatility 147 %
Schedule of options and warrants to employees, officers and directors outstanding	The following table summarizes information about options and warrants to employees, officers and directors outstanding at September 30, 2015 under the plans: Options and Warrants Outstanding Vested and Exercisable Exercise Price Number of Option Weighted Average Remaining Contractual Life (Years) Number of Option weighted Average Exercise Price 0.01 200,000 1.65 125,000 0.01 0.14 3,175,000 4.41 793,750 0.14 0.3 50,000 1.72 50,000 0.30 0.4 50,000 1.72 50,000 0.40 0.5 50,000 1.72 50,000 0.50 0.5763 778,761 2.58 778,761 0.5763 4,303,761 3.78 1,847,511 0.3362

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Sep. 30, 2015
Income Taxes
Schedule of deferred tax assets	Deferred income taxes reflect the net effects of temporary differences between the amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The breakdown of the deferred tax asset as of September 30 2015, 2014 and 2013 is as follows: 2015 2014 2013 U.S. dollars in thousands Deferred tax assets: Net operating loss carry-forward $ 6,331 $ 3,267 $ 2,502 Valuation allowance (6,331 ) (3,267 ) (2,502 ) $ 0 $ 0 $ 0
Summary of valuation allowance	A valuation allowance is provided when it is more likely than not that some portion of the deferred tax asset will not be realized. Management has determined, based on its recurring net losses, lack of a commercially viable product and limitations under current tax rules, that a full valuation allowance is appropriate. U.S. dollars in thousands Valuation allowance, September 30, 2014 $ 3,267 Increase 3,064 Valuation allowance, September 30, 2015 $ 6,331
Schedule of reconciliation of effective tax rate	Reconciliation between the theoretical tax expense, assuming all income is taxed at the statutory tax rate applicable to income of the Company and the actual tax expense as reported in the Statement of Operations, is as follows: Year ended December 31, 2015 2014 2013 Loss before taxes, as reported in the consolidated statements of operations $ 7,462 $ 7,376 $ 1,970 Federal statutory rate 35 % 35 % 35 % Theoretical tax benefit on the above amount at federal statutory tax rate 2,612 2,582 690 Losses and other items for which a valuation allowance Was provided or benefit from loss carry forward (2,612 ) (2,582 ) (690 ) Actual tax expense — — —

GENERAL (Details Narrative)

GENERAL (Details Narrative) $ / shares in Units, $ in Thousands	Dec. 04, 2013shares	Sep. 30, 2015USD ($)	Jun. 30, 2016USD ($)	Dec. 31, 2015USD ($)	Jun. 30, 2015USD ($)	Apr. 08, 2015	Dec. 31, 2014USD ($)	Oct. 02, 2014	Sep. 30, 2014USD ($)	Nov. 26, 2013$ / sharesshares	Sep. 30, 2013USD ($)	Sep. 30, 2012USD ($)
Equity method investment, ownership percentage						30.00%
Preferred stock, shares authorized | shares										500,000,000
Preferred stock, par or stated value per share | $ / shares										$ 0.001
Cash and cash equivalents, at carrying value		$ 161	$ 1,280	$ 2,732	$ 267		$ 118		$ 298		$ 46	$ 22
Working capital deficit		55
Stockholders' equity attributable to parent		(2,694)	(8,287)	(3,689)	$ (2,229)		$ (447)		310		$ (482)	$ (668)
Accumulated deficit		$ (43,404)	$ (51,916)	$ (44,701)					$ (35,942)
Number of biogas facilities				10
Minimum [Member]
Equity method investment, ownership percentage		20.00%
Stock issued during period, shares, reverse stock splits | shares	11,434,611
Maximum [Member]
Equity method investment, ownership percentage		50.00%
Stock issued during period, shares, reverse stock splits | shares	1,292,103,309
Clean Energy Ltd Clean Energy [Member]
Equity method investment, ownership percentage								50.00%

INVESTMENTS IN BLUE SPHERE PA29

INVESTMENTS IN BLUE SPHERE PAVIA (Details Narrative)	Aug. 14, 2015USD ($)	Jul. 17, 2015USD ($)	Jul. 17, 2015EUR (€)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Jun. 30, 2016USD ($)	Jun. 30, 2016EUR (€)	Jun. 30, 2015USD ($)	Dec. 14, 2015USD ($)	Dec. 14, 2015EUR (€)	Sep. 30, 2015USD ($)	Sep. 30, 2014USD ($)	Sep. 30, 2013USD ($)	Dec. 14, 2015EUR (€)	Dec. 08, 2015USD ($)	Dec. 02, 2015USD ($)	Aug. 18, 2015USD ($)	Aug. 14, 2015EUR (€)	May 14, 2015	Apr. 08, 2015
Ownership percentage																				30.00%
Repayment of debt				$ 1,241,000	$ 7,000	$ 1,022,000		$ 963,000			$ 1,081,000	$ 473,000	$ 183,000
Director [Member]
Debt amount																$ 80,000
Performance EBITDA Guarantee [Member]
Monthly EBITDA		$ 204,147
Annual EBITDA		$ 4,082,946
Palas Promissory Note [Member]
Promissory note amount															$ 129,146		$ 211,041
Minimum [Member]
Ownership percentage											20.00%
Maximum [Member]
Ownership percentage											50.00%
Euro | Performance EBITDA Guarantee [Member]
Monthly EBITDA | €			€ 188,000
Annual EBITDA | €			€ 3,760,000
Euro | Palas Promissory Note [Member]
Promissory note amount															$ 118,000		$ 188,000
Share Purchase Agreement [Member]
Ownership percentage									100.00%					100.00%					100.00%
Purchase price									$ 5,646,628
Amount paid at closing									$ 2,143,181
Percentage of purchase price paid at closing									50.00%					50.00%
Share Purchase Agreement [Member] | Euro
Purchase price | €										€ 5,200,000
Amount paid at closing | €										€ 1,952,858
Share Purchase Agreement [Member] | Helios Loan Agreement [Member]
Amount available under loan agreement	$ 5,646,628
Financed investment intial SPVS (percent)	90.00%																	90.00%
Financed investment subsequentled acquired SPVs (percent)	80.00%																	80.00%
Required repayment of loan andd broker fees (percent)	10.00%																	10.00%
Debt interest rate	14.50%																	14.50%
Number of days after closing	90 days
Share Purchase Agreement [Member] | Helios Loan Agreement [Member] | Minimum [Member]
Financed investment SPVS, no repayment (percent)	70.00%																	70.00%
Share Purchase Agreement [Member] | Helios Loan Agreement [Member] | Maximum [Member]
Financed investment SPVS, no repayment (percent)	80.00%																	80.00%
Share Purchase Agreement [Member] | Helios Loan Agreement [Member] | Euro
Amount available under loan agreement | €																		€ 5,000,000
Share Purchase Agreement [Member] | Long Term Mezzanine Loan Agreement [Member]
Debt amount									$ 3,149,081
Repayment of debt						$ 342,192
Share Purchase Agreement [Member] | Long Term Mezzanine Loan Agreement [Member] | Euro
Debt amount | €														€ 2,900,000
Repayment of debt | €							€ 310,204

INVESTMENTS IN JOINT VENTURES (

INVESTMENTS IN JOINT VENTURES (Details Narrative) - USD ($) $ in Thousands	Apr. 08, 2015	Apr. 08, 2015	Jan. 07, 2015	Feb. 28, 2015	Jan. 30, 2015	Jan. 29, 2015	Nov. 19, 2014	Jun. 30, 2016	Dec. 31, 2015	Dec. 14, 2015	Sep. 30, 2015	May 14, 2015
Management fee expense		$ 187,500
Other Assets, noncurrent								$ 6,137	$ 5,920
Ownership percentage	30.00%	30.00%
Development fees and reimbursements received				$ 1,586,000
Public utilities, requested return on equity, percentage		30.00%				30.00%
Distribution made to limited liability company (LLC) member, cash distributions declared					$ 587,500
Members' capital											$ 3,616,978
Business combination, assets and liabilities arising from contingencies, amount recognized, net	$ 1,481,900	$ 1,481,900
Maximum [Member]
Ownership percentage											50.00%
Installment One [Member]
Distribution made to limited liability company (LLC) member, cash distributions declared	$ 562,500
Series B [Member]
Limited liability company (LLC) or limited partnership (LP), members or limited partners, ownership interest	22.75%				25.00%
Limited partners' capital account, units issued					250
Business acquisition, equity interest issued or issuable, number of shares	2,275
Buyer [Member]
Members' capital					$ 1,250,000
Buyer [Member] | Series A [Member]
Limited liability company (LLC) or limited partnership (LP), members or limited partners, ownership interest	77.25%
York Renewable Energy Partners LLC [Member] | Maximum [Member]
Limited liability company (LLC) or limited partnership (LP), members or limited partners, ownership interest					50.00%
York Renewable Energy Partners LLC [Member] | Series A [Member]
Limited liability company (LLC) or limited partnership (LP), members or limited partners, ownership interest	77.25%				75.00%
Limited partners' capital account, units issued					750
Business acquisition, equity interest issued or issuable, number of shares	7,725
York Renewable Energy Partners LLC [Member] | Series B [Member]
Limited liability company (LLC) or limited partnership (LP), members or limited partners, ownership interest					25.00%
OEC Purchase Agreement [Member]
Costs and expenses							$ 900,000
Management fee expense							$ 187,500
Distributable cash flow rate							30.00%
Reimbursement revenue							$ 17,764
Payment for management fee							$ 75,000
OERI Purchase Agreement [Member]
Costs and expenses			$ 300,000
Management fee expense			$ 187,500
Distributable cash flow rate			30.00%
Reimbursement revenue			$ 86,432
Payment for management fee			$ 31,000
Number of days			60 days
Liquidated damages			$ 500
Share Purchase Agreement [Member]
Ownership percentage										100.00%		100.00%
Percentage of equity IRR target												25.00%
Percentage of purchase price at closing												50.00%
Remaining percentage of purchase price after adjustment												50.00%
Annual interest rate after third anniversary												5.00%
Percentage of fees and expenses												50.00%

SIGNIFICANT ACCOUNTING POLICI31

SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	3 Months Ended	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2016	Sep. 30, 2015	Apr. 08, 2015
Ownership percentage				30.00%
Useful life	15 years	15 years
Minimum [Member]
Ownership percentage			20.00%
Maximum [Member]
Ownership percentage			50.00%
Computer software and electronic equipment [Member]
Useful life			3 years
Tools and equipment [Member]
Useful life			5 years
Furniture and fixtures [Member]
Useful life			14 years

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Dec. 31, 2014	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Going Concern Details Narrative
Cash and Cash Equivalents, At Carrying Value	$ 1,280	$ 2,732	$ 161	$ 267	$ 118	$ 298	$ 46	$ 22
Working Capital Deficit	14,456	17,191
Stockholders' Deficit	(8,287)	(3,689)	(2,694)	$ (2,229)	$ (447)	310	$ (482)	$ (668)
Accumulated deficit	$ (51,916)	$ (44,701)	$ (43,404)			$ (35,942)

COMMON SHARES (Details Narrativ

COMMON SHARES (Details Narrative) - USD ($)	Jun. 26, 2016	Jun. 13, 2016	May 18, 2016	Apr. 13, 2016	Mar. 15, 2016	Feb. 15, 2016	Feb. 03, 2016	Feb. 01, 2016	Jan. 26, 2016	Dec. 08, 2014	Sep. 21, 2014	Jan. 09, 2014	Oct. 08, 2013	Nov. 20, 2012	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2014	Jun. 30, 2016	Jun. 30, 2015	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013	Aug. 01, 2016	Feb. 29, 2016
Issuance of shares for services (shares)					85,000			540,000				345,132	88,496			8,035,000
Issuance of shares for services					$ 5,687			$ 36,126							$ 49,000		$ 94,000	$ 262,000	$ 1,336,000	$ 1,574,000	$ 3,220,000	$ 758,000
Warrant exercise term			1 year 6 months
Warrant exercise price																$ 0.1400				$ 0.1400			$ .058
Issuance of common stock (shares)									1,000,000	209,041	280,592			331,859
Value of common stock issued upon new issue											$ 59,000			$ 101,000	$ 188,000			589,000	$ 251,000	$ 347,000	$ 900,000	$ 891,000
Issuance of common stock - share based compensation		$ 585,326																634,000
Issuance of common stock - share based compensation (shares)		7,103,467
Issuance of common stock for debt		$ 145,526
Issuance of common stock for debt (shares)		13,930,742
Issuance of common stock upon exercise of warrants			$ 40,235															$ 41,000
Issuance of common stock upon exercise of warrants (shares)			700,000
Share Purchase Agreement [Member]
Issuance of common stock (shares)	500,000
Warrant [Member]
Warrant exercise term							3 years
Warrant exercise price							$ 0.06
Number of shares called by warrant							1,500,000
Fair value of warrants							$ 87,331
Offering [Member]
Warrant exercise price						$ 0.10
Gross proceeds from subscription agreement						$ 1,925,000
Number of shares called by warrant						17,500,000
Stock shares subscribed						35,000,000
Stock price						$ 0.055
Securities sold in offering (percent)						50.00%
Offering [Member] | Maxim Group LLC [Member]
Warrant exercise price						$ 0.0605
Number of shares called by warrant						2,800,000
Stock shares subscribed						1,400,000
Stock price						$ 0.11
Fair value of warrants						$ 224,413
Offering [Member] | Warrant [Member]
Warrant exercise term						5 years
Warrant exercise price																								$ 0.10
Fair value of warrants						$ 933,358
Offering [Member] | Warrant [Member] | Maxim Group LLC [Member]
Commision rate (percent)						7.00%
Consultant Agreements 9/1/15 & 3/1/16[Member]
Issuance of shares for services (shares)				875,000
Consultant [Member]
Issuance of shares for services (shares)		850,000		1,000,000
Issuance of shares for services		$ 72,625
Consultant- Service Bonus [Member]
Issuance of shares for services (shares)		1,000,000
Issuance of shares for services		$ 165,400

COMMON SHARES (Details Narrat34

COMMON SHARES (Details Narrative 1) - USD ($)	Mar. 15, 2016	Feb. 01, 2016	Jan. 26, 2016	Jun. 17, 2015	Jun. 15, 2015	Jun. 12, 2015	Apr. 15, 2015	Jan. 05, 2015	Dec. 08, 2014	Sep. 21, 2014	Mar. 10, 2014	Jan. 09, 2014	Dec. 13, 2013	Oct. 08, 2013	Sep. 30, 2013	Sep. 03, 2013	Jul. 22, 2013	Jun. 26, 2013	Jun. 19, 2013	May 10, 2013	Apr. 10, 2013	Mar. 10, 2013	Jan. 03, 2013	Dec. 25, 2012	Dec. 20, 2012	Nov. 20, 2012	Nov. 05, 2012	Oct. 25, 2012	Feb. 20, 2012	Apr. 30, 2015	Feb. 28, 2013	Jan. 31, 2013	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2014	Jun. 30, 2016	Jun. 30, 2015	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013	Aug. 01, 2016	Jun. 23, 2015	Nov. 26, 2013
Number of common stock issued for services	85,000	540,000										345,132		88,496																				8,035,000
Value of common stock issued for services												$ 89,734																					$ 49,000		$ 94,000	$ 262,000	$ 1,336,000	$ 1,574,000	$ 3,220,000	$ 758,000
Number of common stock issued upon new issue			1,000,000						209,041	280,592																331,859
Value of common stock issued upon new issue										$ 59,000																$ 101,000							$ 188,000			589,000	$ 251,000	$ 347,000	$ 900,000	$ 891,000
Exercise price (in dollars per shares)																																		$ 0.1400				$ 0.1400			$ .058
Preferred shares, par value (in dollars per share)																																											$ 0.001
Preferred shares, shares authorized																																											500,000,000
Conversion of warrants																																				$ 41,000
Warrant [Member]
Conversion of warrants																														$ 48,549
Mr. Shlomi Palas [Member]
Number of common stock issued for services											250,000		424,779														53,098
Mr. Josh Shoham [Member]
Number of common stock issued for services											220,000		353,982														44,248
Mr. Roy Amitzur [Member]
Number of common stock issued for services											200,000		353,982														44,248
Mr. Mark Radom [Member]
Number of common stock issued for services																											35,399
Dr. Borenstein Ltd (Subscription Agreement) [Member]
Exercise price (in dollars per shares)								$ 0.001
Consultant [Member]
Number of common stock available for future issuance																													35,399
Number of common stock issued for services					1,500,000																								17,700
Value of common stock issued for services					$ 34,500
Non-US Investor (Subscription Agreement) [Member]
Number of common stock issued upon new issue															88,496	268,169	268,169	53,098	132,744	88,496	88,496	88,496		265,487	309,735			88,496			154,868	154,868
Value of common stock issued upon new issue																$ 100,000	$ 100,000	$ 20,000	$ 50,000					$ 70,000	$ 100,000			$ 20,000			$ 50,000	$ 50,000
Share price																									$ 0.32286
Number of additional common stock issued upon new issue																															88,496
Fair value of options																															$ 76,000
Professional fees																							$ 11,000
Non-US Investor (Subscription Agreement) [Member] | First Stock Option [Member]
Share price																															$ 2.26
Number of shares options to purchase																															66,372
Expiration period																															1 year
Non-US Investor (Subscription Agreement) [Member] | Second Stock Option [Member]
Share price																															$ 4.52
Number of shares options to purchase																															66,372
Expiration period																															2 years
Non-US Investor (Subscription Agreement) [Member]
Number of common stock issued upon new issue																			53,634									380,531
Value of common stock issued upon new issue																			$ 20,000									$ 50,000
Dr. Borenstein Ltd (Subscription Agreement) [Member]
Number of common stock issued upon new issue						8,484,848	1,630,000																															1,000,000
Value of common stock issued upon new issue						$ 140,000	$ 48,000
Number of shares options to purchase								1,000,000
Value of common stock options								$ 158,024
Number of stock options issued								1,000,000
Share Repurchase Program [Member]
Maximum number of authorized shares repurchase				500,000																																						144,054
Number of common stock equates				16,666,667
Shareholder settlement amount																																										$ 28,328

COMMON SHARES (Details Narrat35

COMMON SHARES (Details Narrative 2) - USD ($)	May 18, 2016	Mar. 15, 2016	Feb. 01, 2016	Jan. 26, 2016	Sep. 17, 2015	Jul. 17, 2015	Jul. 06, 2015	Jul. 02, 2015	Jun. 12, 2015	Apr. 15, 2015	Apr. 13, 2015	Mar. 12, 2015	Jan. 05, 2015	Dec. 08, 2014	Oct. 28, 2014	Oct. 03, 2014	Sep. 22, 2014	Sep. 21, 2014	Jul. 29, 2014	Jul. 10, 2014	Jul. 03, 2014	Jun. 18, 2014	Jun. 01, 2014	May 27, 2014	May 25, 2014	May 02, 2014	May 01, 2014	Apr. 22, 2014	Mar. 10, 2014	Mar. 05, 2014	Feb. 07, 2014	Jan. 26, 2014	Jan. 09, 2014	Dec. 15, 2013	Dec. 13, 2013	Dec. 04, 2013	Nov. 14, 2013	Nov. 05, 2013	Oct. 13, 2013	Oct. 08, 2013	Sep. 30, 2013	Sep. 03, 2013	Jul. 22, 2013	Jun. 26, 2013	Jun. 23, 2013	Jun. 19, 2013	May 10, 2013	Apr. 30, 2013	Apr. 10, 2013	Mar. 18, 2013	Mar. 10, 2013	Feb. 02, 2013	Jan. 03, 2013	Dec. 25, 2012	Dec. 20, 2012	Nov. 20, 2012	Nov. 05, 2012	Oct. 25, 2012	Aug. 31, 2015	Jul. 31, 2015	May 31, 2015	Apr. 30, 2015	Mar. 19, 2015	Oct. 31, 2014	Jul. 31, 2014	Oct. 30, 2013	Feb. 28, 2013	Jan. 31, 2013	Jun. 30, 2015	Aug. 31, 2014	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Jul. 31, 2013	Jun. 30, 2016	Jun. 30, 2015	Aug. 31, 2015	Jun. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013	Aug. 01, 2016	Apr. 08, 2015	Sep. 28, 2014	Feb. 20, 2013	Feb. 19, 2013
Number of common stock issued for services		85,000	540,000																														345,132							88,496																																8,035,000
Value of common stock issued for services																																	$ 89,734																																						$ 49,000		$ 94,000				$ 262,000	$ 1,336,000			$ 1,574,000	$ 3,220,000	$ 758,000
Number of common stock issued upon new issue				1,000,000										209,041				280,592																																						331,859
Value of common stock issued upon new issue																		$ 59,000																																						$ 101,000															$ 188,000						$ 589,000	$ 251,000			$ 347,000	$ 900,000	891,000
Beneficial principal loan converted																																																																															$ 1,480,716
Number of shares issued upon conversion																																																																															75,060,414
Ownership percentage																																																																																					30.00%
Exercise price (in dollars per shares)																																																																								$ 0.1400									$ 0.1400			$ .058
Warrant term	1 year 6 months
Investment Agreements [Member]
Number of common stock issued upon new issue																																																																										880,000
Value of common stock issued upon new issue																																																																										$ 109,721
Number of shares options to purchase																																																																										822,500
Exercise price of options (in dollars per shares)																																																																										$ 0.10
Investment Agreements [Member]
Number of common stock issued upon new issue																																																																										759,041
Value of common stock issued upon new issue																																																																										$ 77,127
Share price																																																																																						$ 0.13
Number of additional common stock issued upon new issue																																																																										759,041
Number of shares options to purchase																																																																										759,041
Exercise price of options (in dollars per shares)																																																																										$ 0.10
Investment Agreements [Member]
Number of common stock issued upon new issue																																																																										352,805
Value of common stock issued upon new issue																																																																										$ 98,784
Number of shares options to purchase																																																																										352,805
Exercise price of options (in dollars per shares)																																																																										$ 0.60
Investment Agreements [Member]
Number of common stock issued upon new issue																																																																										199,039
Value of common stock issued upon new issue																																																																										$ 19,904
Share price																																																																										$ 0.16								$ 0.16
Number of additional common stock issued upon new issue																																																																										199,039
Number of shares options to purchase																																																																										199,039
Exercise price of options (in dollars per shares)																																																																										$ 0.13
Service Agreement [Member]
Number of common stock issued for services															335,000
Service Agreement [Member]
Number of common stock issued for services															335,000
Additional beneficial principal loan converted															$ 42,500
Number of additional shares issued upon conversion															471,967
Mr. Shlomi Palas [Member]
Number of common stock issued for services																													250,000						424,779																						53,098
Mr. Josh Shoham [Member]
Number of common stock issued for services																													220,000						353,982																						44,248
Mr. Roy Amitzur [Member]
Number of common stock issued for services																													200,000						353,982																						44,248
Mr. Mark Radom [Member]
Number of common stock issued for services																													180,000						283,186
Consultant [Member]
Number of common stock issued for services																								180,000									17,700
Value of common stock issued for services																								$ 7,560									$ 4,602
8% Asher Notes [Member]
Beneficial principal loan converted																																																																$ 42,500		$ 47,878
Number of shares issued upon conversion																																																																471,967		402,276
Non-US Investor (Subscription Agreement) [Member]
Number of common stock issued upon new issue																																									88,496	268,169	268,169	53,098		132,744	88,496		88,496		88,496			265,487	309,735			88,496									154,868	154,868
Value of common stock issued upon new issue																																										$ 100,000	$ 100,000	$ 20,000		$ 50,000								$ 70,000	$ 100,000			$ 20,000									$ 50,000	$ 50,000
Share price																																																							$ 0.32286
Number of additional common stock issued upon new issue																																																																			88,496
Fair value of options																																																																			$ 76,000
Professional fees																																																					$ 11,000
Aggregate investments																																																																																								$ 75,000
Aggregate periodic investments																																									$ 25,000						$ 25,000		$ 25,000		$ 25,000																																25,000
Beneficial principal loan converted																																							$ 87,000
Number of shares issued upon conversion																																							384,956																										190,000
Non-US Investor (Subscription Agreement) [Member] | Restricted Common Stock Class [Member]
Number of common stock issued upon new issue																																																					39,824
Value of common stock issued upon new issue																																																					$ 11,000
Investor [Member]
Number of common stock issued for services												109,039																					265,486																			451,328								8,035,000	3,250,000		6,114,867						3,765,000
Value of common stock issued for services												$ 14,103																					$ 25,000																			$ 50,000								$ 198,614	$ 136,500		$ 738,353						$ 150,118
Number of common stock issued upon new issue																		48,183	144,054		1,250,000																																									144,054														495,576
Value of common stock issued upon new issue																		$ 11,557	$ 34,522		$ 75,000																																																							$ 49,315
Number of additional common stock issued upon new issue																				75,000
Number of shares options to purchase																		48,183	144,054
Beneficial principal loan converted																				$ 24,000
Number of shares issued upon conversion																				115,000
Exercise price of options (in dollars per shares)																		$ 0.32	$ 0.10
Investor [Member] | OERI Purchase Agreement [Member]
Number of common stock issued upon new issue																																				44,248
Aggregate investments																																				$ 480,000
Ownership percentage																																				4.00%
Investor [Member] | OERI Purchase Agreement [Member] | Euro [Member]
Aggregate investments																																				$ 353,200
Investor [Member] | Notes [Member] | OERI Purchase Agreement [Member] | Euro [Member]
Debt face amount																																				$ 353,200
Monthly debt instruments interest rate																																				1.00%
Non-US Investor (Subscription Agreement) [Member]
Number of common stock issued upon new issue																																									35,399						146,903		146,903		146,903
Aggregate investments																																																																																							$ 50,000
Aggregate periodic investments																																									$ 4,000						$ 16,700		$ 16,600		$ 16,600																																$ 4,000
Mr. Shlomi Palas [Member]
Number of common stock issued for services																																														53,098		230,089		53,098
Number of shares options to purchase																																																230,089
Mr. Josh Shoham [Member]
Number of common stock issued for services																																														44,248		203,540		44,248
Number of shares options to purchase																																																203,540
Mr. Roy Amitzur [Member]
Number of common stock issued for services																																														44,248		168,142		44,248
Number of shares options to purchase																																																168,142
Mr. Mark Radom [Member]
Number of common stock issued for services																																														35,399		88,496		35,399
Number of shares options to purchase																																																88,496
Third Party [Member]
Number of common stock issued for services																							179,856																						156,611	176,992
Value of common stock issued for services																							$ 28,874
Number of shares options to purchase																							179,856
Exercise price of options (in dollars per shares)																							$ 0.25
Non-US Investor (Subscription Agreement) [Member]
Number of common stock issued upon new issue																																														53,634												380,531
Value of common stock issued upon new issue																																														$ 20,000												$ 50,000
Beneficial principal loan converted																																							$ 37,000
Number of shares issued upon conversion																																							163,717
Incline Partners, LLC (Capital Markets Advisory Consulting Agreement ) [Member]
Professional fees																																												$ 28,000
Incline Partners, LLC (Capital Markets Advisory Consulting Agreement ) [Member] | Restricted Common Stock Class [Member]
Number of common stock issued for services																																												88,496
Eastern Sphere Ltd [Member]
Number of common stock issued for services																																					146,016	491,642
Value of common stock issued for services																																					$ 29,107	$ 100,000
Consultant (Investor Relation Services) [Member]
Number of common stock issued for services																										211,084								600,000
Value of common stock issued for services																										$ 41,518
Talya Levy-Tytiun (Subscription Agreement) [Member]
Number of common stock issued for services					2,866,194																											1,739,130
Share price																																$ 0.23
Aggregate investments																																$ 400,000
Changing the World Technologies, Ltd. [Member]
Number of common stock issued for services																															1,200,000
Aggregate investments																															$ 77,000
Non-US Investor (Consulting Agreement) [Member]
Number of common stock issued for services																												4,000,000																																										650,000				3,350,000
Number of common stock issued upon new issue																																																																						3,969,133
Value of common stock issued upon new issue																																																																						$ 970,573
Non-US Investor (Three Agreement) [Member]
Number of common stock issued for services																												2,177,000
Value of common stock issued for services																												$ 481,810
Number of common stock issued upon new issue																																																																											800,892
Number of additional common stock issued upon new issue																																																																											380,435
Value of additional common stock issued upon new issue																																																																											$ 69,000
Loan carrying amount																																																																											$ 78,400					$ 78,400
Carter Terry [Member]
Number of common stock issued for services														209,041
Non-US Citizen (Consulting Agreement) [Member]
Number of common stock issued for services																2,000,000
Value of common stock issued for services																$ 216,828
Number of shares options to purchase																500,000
Exercise price of options (in dollars per shares)																$ 0.001
Maxim Group LLC (Financial Advisor & Investment Banker Agreement) [Member]
Number of common stock issued for services																																																											3,474,405
Value of common stock issued for services																																																											$ 34,397
Non-US Person (Financial Advisor & Investment Banker Settlement Agreement) [Member]
Number of common stock issued for services																																																											1,128,237
Value of common stock issued for services																																																											$ 13,088
Non-US Person (Subscription Agreement) [Member]
Number of common stock issued upon new issue								2,000,000			416,667
Value of common stock issued upon new issue								$ 32,000			$ 25,000
Dr. Borenstein Ltd (Subscription Agreement) [Member]
Number of common stock issued upon new issue									8,484,848	1,630,000																																																																							1,000,000
Value of common stock issued upon new issue									$ 140,000	$ 48,000
Number of shares options to purchase													1,000,000
Non-US Entity (Subscription Agreement) [Member]
Number of common stock issued upon new issue							2,428,571
Value of common stock issued upon new issue							$ 51,000
Non-US Personnel (Subscription Agreement) [Member]
Number of common stock issued upon new issue						2,318,183
Value of common stock issued upon new issue						$ 39,394
Eastern Institutional Funding, LLC [Member] | Notes [Member]
Ownership percentage																														20.00%
Debt face amount																														$ 68,750
Debt instrument,term																														1 year
Capitoline Ventures II, LLC [Member] | Notes [Member]
Ownership percentage																														20.00%
Debt face amount																														$ 68,750
Debt instrument,term																														1 year
Eastern Institutional Funding, LLC & Capitoline Ventures II, LLC [Member] | Notes [Member]
Number of shares issued upon conversion																																																																	1,320,000															5,114,073
Investor (Consulting Agreement) [Member]
Number of common stock issued for services																	2,484,000										2,819,000
Number of warrants called																											1,193,000
Exercise price (in dollars per shares)																											$ 0.10
Warrant term																											1 year
Investor (Investor Relations Services) [Member]
Number of common stock issued for services																	300,000								350,000
Value of common stock issued for services																	$ 90,000								$ 54,600
Share price																									$ 0.20
Number of shares options to purchase																	1,500,000
Expiration period																	5 years
Fair value of options																	$ 151,434
Exercise price of options (in dollars per shares)																	$ 0.10
Number of warrants called																									350,000
Exercise price (in dollars per shares)																									$ 0.20
Warrant term																									6 months
Monthly professional fees																									$ 18,000
Warrant issue expenses																									28,310
Accredited Investor [Member]
Number of common stock issued for services																				75,000		150,000
Value of common stock issued for services																				$ 52,800
Number of warrants called																						150,000
Warrant term																						3 years
Investor (Consulting Agreement) [Member]
Number of common stock issued for services																	963,000
Value of common stock issued for services																	$ 52,708
Investor (Investor Relations Services) [Member]
Number of common stock issued for services																	500,000
Value of common stock issued for services																	$ 216,828
Investor (Investor Relations Services) [Member]
Number of common stock issued for services																									150,000

COMMON SHARES (Details)

COMMON SHARES (Details) - Warrant [Member]	Feb. 15, 2016	Feb. 03, 2016
Dividend yield		0.00%
Risk-free interest rate		1.20%
Expected term		3 years
Volatility		203.00%
Offering [Member]
Dividend yield	0.00%
Risk-free interest rate	1.20%
Expected term	5 years
Volatility	203.00%

COMMON SHARES (Details 1)

COMMON SHARES (Details 1) - Warrant [Member]	Feb. 15, 2016	Feb. 03, 2016
Dividend yield		0.00%
Risk-free interest rate		1.20%
Expected term		3 years
Volatility		203.00%
Offering [Member]
Dividend yield	0.00%
Risk-free interest rate	1.20%
Expected term	5 years
Volatility	203.00%
Offering [Member] | Maxim Group LLC [Member]
Dividend yield	0.00%
Risk-free interest rate	1.20%
Expected term	5 years
Volatility	203.00%

WARRANTS, DEBENTURES AND NOTE38

WARRANTS, DEBENTURES AND NOTES (Details Narrative) - USD ($)	May 18, 2016	Feb. 03, 2016	Dec. 23, 2015	Mar. 31, 2016	Aug. 01, 2016	Nov. 01, 2015	Sep. 30, 2015
Warrant exercise price					$ .058		$ 0.1400
Warrant exercise term	1 year 6 months
Senior Debentures [Member]
Offering amount						$ 3,000,000
Number of shares called by warrant						8,000,000
Warrant exercise term				5 years
Fair value of warrants						$ 208,597
Percent exercisable at different pricing						50.00%
Debt interest rate						11.00%
Debt term				2 years
Pledged collateral - common stock						49.00%
Gross proceeds from debenture offering subscription agreement			$ 3,000,000
Senior Debentures [Member] | Maxim Group LLC [Member]
Warrant exercise price			$ .06875
Fair value of warrants			$ 116,599
Commision rate (percent)				7.00%
Issuance of warrants for services (shares)				4,848,000
Senior Debentures [Member] | First 50% [Member]
Warrant exercise price						$ 0.05
Senior Debentures [Member] | Second 50% [Member]
Warrant exercise price						$ 0.075
Warrant [Member]
Number of shares called by warrant		1,500,000
Warrant exercise price		$ 0.06
Warrant exercise term		3 years
Fair value of warrants		$ 87,331

DEBENTURES, NOTES AND LOANS (De

DEBENTURES, NOTES AND LOANS (Details Narrative) - USD ($)	Jun. 13, 2016	Jan. 26, 2016	Jan. 20, 2015	Dec. 08, 2014	Sep. 30, 2014	Sep. 21, 2014	Nov. 20, 2012	Dec. 31, 2014	Jun. 30, 2015	Aug. 31, 2015	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2014	May 10, 2013
Principal amount notes	$ 145,526
Debt instrument issue of shares	13,930,742
Amounts allocated to additional paid-in capital								$ 322,000	$ 181,000		$ 482,000		$ 1,041,000
Number of common stock issued upon new issue		1,000,000		209,041		280,592	331,859
MD Global Partners [Member]
Debt face amount											$ 480,000
Debt instrument,term											1 year
Minimum accrue interest rates											8.00%
Maximum accrue interest rates											18.00%
Minimum interest rates of the notes											12.00%
Maximum interest rates of the notes											24.00%
Minimum interest rates of conversion prices											37.00%
Maximum interest rates of conversion prices											45.00%
Amounts allocated to additional paid-in capital											$ 482,485
Amortization expenses in respect of the discounts											1,523,404
Debt issuance cost											7,500
Carter Terry [Member]
Debt issuance cost											$ 46,000
Number of shares											100,000
Debt issuance percentage											4.00%
Notes [Member]
Principal amount notes											$ 464,970
Debt instrument conversion amount										$ 1,480,716
Debt instrument issue of shares										75,060,414
Notes [Member] | Accredited Investor [Member]
Debt face amount			$ 504,250		$ 1,408,150							$ 1,408,150	$ 1,408,150
Principal amount notes			$ 464,970		$ 1,201,414							1,201,414
Amounts allocated to additional paid-in capital												$ 1,040,919
6.5% Convertible Notes Payable [Member] | DA [Member] | Fidelity [Member]
Conversion price (in dollars per share)														$ 0.2034

DEBENTURES, NOTES AND LOANS (40

DEBENTURES, NOTES AND LOANS (Details Narrative 1) - USD ($)	Jun. 13, 2016	Mar. 25, 2015	Mar. 15, 2015	Sep. 30, 2015	Mar. 07, 2012
Debt instrument conversion of shares	13,930,742
Eastern Sphere Ltd [Member]
Debt instrument conversion amount				$ 88,496
Mr. Weinberg [Member]
Debt face amount					$ 135,000
Ackerman Loan Agreement [Member]
Debt instrument conversion amount			$ 220,000
Debt instrument conversion of shares			3,000,000
Valter Team Loan Agreement [Member]
Debt instrument conversion amount		$ 68,750
Debt instrument conversion of shares		250,000

WARRANTS, DEBENTURES AND NOTE41

WARRANTS, DEBENTURES AND NOTES (Details)	Feb. 03, 2016	Dec. 23, 2015
Senior Debentures - Warrants [Member]
Dividend yield		0.00%
Risk-free interest rate		1.74%
Expected term		5 years
Volatility		202.00%
Senior Debentures - Warrants [Member] | Maxim Group LLC [Member]
Dividend yield		0.00%
Risk-free interest rate		1.74%
Expected term		5 years
Volatility		202.00%
Warrant [Member]
Dividend yield	0.00%
Risk-free interest rate	1.20%
Expected term	3 years
Volatility	203.00%

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Mar. 15, 2016	Feb. 01, 2016	Jan. 26, 2016	Dec. 08, 2014	Sep. 21, 2014	Sep. 17, 2014	May 27, 2014	Mar. 10, 2014	Jan. 26, 2014	Jan. 09, 2014	Dec. 13, 2013	Oct. 08, 2013	Jul. 31, 2013	Apr. 30, 2013	Apr. 10, 2013	Nov. 20, 2012	Nov. 05, 2012	Feb. 29, 2012	Jul. 25, 2011	Feb. 24, 2015	Feb. 24, 2015	Sep. 30, 2015	Jun. 30, 2016	Dec. 31, 2015	Sep. 30, 2014	Jun. 19, 2013	Mar. 18, 2013	Nov. 06, 2012
Number of common stock issued upon new issue			1,000,000	209,041	280,592											331,859
Common stock, shares issued																						167,952,595	243,051,884	180,502,443	50,109,036
Stock issued during period, shares, issued for services	85,000	540,000								345,132		88,496										8,035,000
2014 Plan [Member]
Vesting period																					2 years
Share price																				$ 0.14	$ 0.14
Subscription Agreement [Member]
Number of common stock issued upon new issue						2,866,194
Executive Vice President [Member]
Payment for management fee													$ 15,000
Aggregate cost of investment													$ 2,000,000						$ 450,000
Share-based compensation arrangement by share-based payment award, number of shares authorized								200,000			353,982			168,142												44,248	44,248	44,248
Share-based compensation arrangement by share-based payment award, shares purchased for award														168,142
Stock issued during period, shares, issued for services								200,000			353,982						44,248
Executive Vice President [Member] | Management Services Agreement [Member]
Related party transaction, rate																			75.00%
Payment for management fee																			$ 10,000
Number of common stock issued upon new issue																			110,620
Chief Executive Officer [Member]
Aggregate cost of investment																			$ 2,000,000
Share-based compensation arrangement by share-based payment award, number of shares authorized								250,000			424,779			203,540												53,098	53,098	53,098
Share-based compensation arrangement by share-based payment award, shares purchased for award														230,089
Stock issued during period, shares, issued for services								250,000			424,779						53,098
Chief Executive Officer [Member] | Employment Agreement [Member]
Payment for management fee																		$ 15,000
Board Of Directors Chairman [Member]
Share-based compensation arrangement by share-based payment award, number of shares authorized								220,000			353,982			230,089												44,248	44,248	44,248
Share-based compensation arrangement by share-based payment award, shares purchased for award														203,540
Stock issued during period, shares, issued for services								220,000			353,982						44,248
Chief Carbon Officer General Counsel [Member]
Share-based compensation arrangement by share-based payment award, number of shares authorized								180,000			283,186			88,496												35,399	35,399	35,399
Share-based compensation arrangement by share-based payment award, shares purchased for award														88,496
Stock issued during period, shares, issued for services								180,000			283,186
Mr. Radom [Member] | Service and Consulting Agreement [Member]
Related party transaction, rate															75.00%
Mr. Radom [Member] | Service and Consulting Agreement [Member] | Minimum [Member]
Payment for management fee															$ 7,000
Mr. Radom [Member] | Service and Consulting Agreement [Member] | Maximum [Member]
Payment for management fee															$ 10,000
Talya Levy-Tytiun ("Talya") [Member] | Subscription Agreement [Member]
Debt instrument, face amount									$ 400,000
Common stock, shares issued									1,739,130
Description of subscription agreement									The Company was obligated to issue Talya additional shares of the Company, if, six months from the date of the agreement her ownership in the Company would be reduced below 12.3%. In addition, the Company guaranteed that if on the first anniversary of the agreement, the share price of the Company common stock was 0.23$ per share or less, the Company shall transfer Talya such amount necessary to make Talya whole and reimburse her for any loss due to her investment.
Mr. Brosh [Member]
Number of shares granted							200,000
Weighted average exercise price							$ 0.01
Vesting period							2 years
Management [Member]
Number of shares granted																				1,775,000
Vesting period																				2 years
Stock issued during period, shares, issued for services																				7,450,000
Management [Member] | Stock Compensation Plan [Member]
Number of shares granted																				1,450,000

STOCK OPTIONS (Details Narrativ

STOCK OPTIONS (Details Narrative) - USD ($)	Jun. 13, 2016	Feb. 24, 2015	Sep. 30, 2015	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Common stock issued under plan	7,103,467
Stock Option [Member]
Fair value of the options				$ 0.111	$ 0.192	$ 0.565
Allocated share-based compensation expense				$ 231	$ 1,711	$ 203
Aggregated intrinsic value vested and exercisable options			$ 2,500	$ 2,500
Weighted average contractual term				1 year 7 months 24 days
Unrecognized compensation expense			$ 249,962	$ 249,962
Period for recognition				1 year 6 months
2010 Plan [Member]
Number of shares available under plan		2,575,000
Common stock issued under plan			1,875,000
2014 Plan [Member]
Number of shares available under plan		13,100,000
Share-based compensation arrangement by share-based payment award, award vesting period		2 years
Share price		$ 0.14
2014 Plan [Member] | Stock Option [Member]
Number of shares available under plan		3,175,000
Minimum [Member]
Fair value of the options					$ 0.190
Maximum [Member]
Fair value of the options					$ 0.214

STOCK OPTIONS (Details)

STOCK OPTIONS (Details) - Stock Option [Member] - $ / shares	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Number of options:
Outstanding, beginning	1,128,761	778,761
Granted	3,175,000	350,000
Outstanding, ending	4,303,761	1,128,761
Number of options exercisable	1,847,511	684,071
Weighted Average Exercise Price:
Outstanding, beginning	$ 0.4530	$ 0.5763
Granted	0.1400	0.1770
Outstanding, ending	0.2220	0.4530
Number of options exercisable	$ 0.3362	$ 0.5363

STOCK OPTIONS (Details 1)

STOCK OPTIONS (Details 1)	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Dividend yield	0.00%	0.00%	0.00%
Risk-free interest rate	1.47%	0.88%	0.32%
Expected term	5 years	3 years	5 years
Volatility	147.00%		390.00%
Minimum [Member]
Volatility		123.00%
Maximum [Member]
Volatility		157.00%

STOCK OPTIONS (Details 2)

STOCK OPTIONS (Details 2)	12 Months Ended
	Sep. 30, 2015$ / sharesshares
Number of options and warrants outstanding	4,303,761
Options and warrants outstanding weighted average remaining contractual life	3 years 9 months 11 days
Number of option vested and exercisable	1,847,511
$0.01 [Member]
Number of options and warrants outstanding	200,000
Options and warrants outstanding weighted average remaining contractual life	1 year 7 months 24 days
Number of option vested and exercisable	125,000
Vested and exercisable weighted average exercise price | $ / shares	$ 0.01
$0.14 [Member]
Number of options and warrants outstanding	3,175,000
Options and warrants outstanding weighted average remaining contractual life	4 years 4 months 28 days
Number of option vested and exercisable	793,750
Vested and exercisable weighted average exercise price | $ / shares	$ 0.14
$0.3 [Member]
Number of options and warrants outstanding	50,000
Options and warrants outstanding weighted average remaining contractual life	1 year 8 months 19 days
Number of option vested and exercisable	50,000
Vested and exercisable weighted average exercise price | $ / shares	$ 0.30
$0.4 [Member]
Number of options and warrants outstanding	50,000
Options and warrants outstanding weighted average remaining contractual life	1 year 8 months 19 days
Number of option vested and exercisable	50,000
Vested and exercisable weighted average exercise price | $ / shares	$ 0.40
$0.5 [Member]
Number of options and warrants outstanding	50,000
Options and warrants outstanding weighted average remaining contractual life	1 year 8 months 19 days
Number of option vested and exercisable	50,000
Vested and exercisable weighted average exercise price | $ / shares	$ 0.50
$0.5763 [Member]
Number of options and warrants outstanding	778,761
Options and warrants outstanding weighted average remaining contractual life	2 years 6 months 29 days
Number of option vested and exercisable	778,761
Vested and exercisable weighted average exercise price | $ / shares	$ 0.5763

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2014	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2013
Statutory income tax rate	35.00%	35.00%	35.00%		35.00%
Net operating loss carry-forward		$ 14,130
Israeli Subsidiaries [Member]
Effective income tax rate		25.00%		26.50%		25.00%
Net operating loss carry-forward		$ 3,138

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Deferred tax assets:
Net operating loss carry-forward	$ 6,331	$ 3,267	$ 2,502
Valuation allowance	(6,331)	(3,267)	(2,502)
Deferred tax assets, net of valuation allowance	$ 0	$ 0	$ 0

INCOME TAXES (Details 1)

INCOME TAXES (Details 1) $ in Thousands	12 Months Ended
	Sep. 30, 2015USD ($)
Income Tax Disclosure [Abstract]
Valuation allowance, begining	$ 3,267
Increase	3,064
Valuation allowance, ending	$ 6,331

INCOME TAXES (Details 2)

INCOME TAXES (Details 2) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Loss before taxes, as reported in the consolidated statements of operations	$ 7,462		$ 7,376	$ 1,970
Federal statutory rate	35.00%	35.00%	35.00%	35.00%
Tax benefit at federal statutory tax rate	$ 2,612		$ 2,582	$ 690
Losses and other items for which a valuation allowance was provided or benefit from loss carry forward	$ (2,612)		$ (2,582)	$ (690)

NET LOSS PER SHARE DATA (Detail

NET LOSS PER SHARE DATA (Details) - Stock Option [Member] - $ / shares	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Options:
Weighted average number	1,847,511	684,071	194,690
Weighted average exercise price	$ 0.3362	$ 0.5363	$ 0.5763

OTHER LOSS (INCOMES) (Details N

OTHER LOSS (INCOMES) (Details Narrative) - CTG Clean Technology Group Limited [Member] - USD ($) $ in Thousands	1 Months Ended
	May 30, 2015	Jan. 31, 2012
Loan receivable		$ 30
Interest rate		8.00%
Recovery of loan previously written-off	$ 38

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)

Jul. 26, 2016

Jul. 07, 2016

May 18, 2016

Jan. 26, 2016

Dec. 14, 2015

Oct. 21, 2015

Aug. 18, 2015

Jun. 12, 2015

Apr. 15, 2015

Dec. 08, 2014

Sep. 21, 2014

Nov. 20, 2012

Feb. 15, 2016

Jul. 31, 2016

Sep. 30, 2015

Aug. 01, 2016

Dec. 08, 2015

Number of common stock issued upon new issue

1,000,000

209,041

280,592

331,859

Warrant exercise price

$ 0.1400

$ .058

Warrant exercise term

1 year 6 months

Palas Promissory Note [Member]

Loan amount

$ 211,041

$ 129,146

Helios Loan Agreement [Member]

Amount available under loan agreement

$ 5,612,796

Interest rate

14.50%

Percentage of financing under loan agreement

90.00%

Percentage of total required investment under loan agreement

80.00%

Percentage of repayment of loan and broker fees

10.00%

Number of days after loan closing

90 days

Helios Loan Agreement [Member] | Minimum [Member]

Percentage of total required investment under loan agreement

70.00%

Helios Loan Agreement [Member] | Maximum [Member]

Percentage of total required investment under loan agreement

80.00%

Euro [Member] | Palas Promissory Note [Member]

Loan amount

$ 188,000

$ 118,000

Euro [Member] | Helios Loan Agreement [Member]

Amount available under loan agreement

$ 5,000,000

Dr. Borenstein Ltd (Subscription Agreement) [Member]

Number of common stock issued upon new issue

8,484,848

1,630,000

1,000,000

Subsequent Event - Offering [Member]

Gross proceeds from subscription agreement

$ 1,925,000

Number of shares subscribed per offering

35,000,000

Share price

$ 0.055

Number of shares called by warrant

17,500,000

Warrant exercise price

$ 0.10

Warrant exercise term

5 years

Securities sold in offering (percent)

50.00%

Subsequent Event - Offering [Member] | Maxim Group LLC [Member]

Commision rate (percent)

7.00%

Securities sold in offering (percent)

8.00%

Exercise price of warrants (percent)

110.00%

Subsequent Event - Offering [Member] | June Offering [Member]

Offering amount

$ 3,000,000

Number of shares subscribed per offering

18,266,668

Share price

$ 0.075

Number of shares called by warrant

18,266,668

Warrant exercise price

$ 0.11

$ .011

Warrant exercise term

5 years

Number of days to register common stock

20 days

Aggregate gross proceeds from closings of offerings

$ 1,370,000

Subsequent Event - Offering [Member] | June Offering [Member] | Maxim Group LLC [Member]

Warrant exercise price

$ 0.0121

$ 0.0825

Commision rate (percent)

4.40%

Issuance of warrants for services (shares)

928,000

928,000

Subsequent Event - Offering [Member] | Minimum [Member] | June Offering [Member]

Minimum subsequent offerings

$ 1,000,000

Subsequent Event - Offering [Member] | Dr. Borenstein Ltd (Subscription Agreement) [Member]

Number of common stock issued upon new issue

1,630,000

Subsequent Event - June Subscription Agreement [Member] | Dr. Borenstein Ltd (Subscription Agreement) [Member]

Number of common stock issued upon new issue

8,484,848

Subsequent Event [Member] | EBITDA Agreement [Member]

Annual EBITDA guarantee

$ 4,220,823

Monthly EBITDA guarantee

211,041

Subsequent Event [Member] | Euro [Member] | EBITDA Agreement [Member]

Annual EBITDA guarantee

3,760,000

Monthly EBITDA guarantee

188,000

Subsequent Event [Member] | Kinexia S.p.A. [Member]

Aggregate purchase price

5,837,308

Loan amount - financing purchase price

$ 3,255,422

Percentage acquired

100.00%

Percentage of purchase price paid at closing

50.00%

Subsequent Event [Member] | Kinexia S.p.A. [Member] | Euro [Member]

Aggregate purchase price

$ 5,200,000

Loan amount - financing purchase price

$ 2,900,000

SUBSEQUENT EVENTS (Details Na54

SUBSEQUENT EVENTS (Details Narrative 1) - USD ($)	May 18, 2016	Feb. 03, 2016	Dec. 23, 2015	Nov. 30, 2015	Aug. 01, 2016	Jun. 30, 2016	Dec. 31, 2015	Sep. 30, 2015	Sep. 30, 2014
Common shares, par value (in dollars per share)						$ 0.001	$ 0.001	$ 0.001	$ 0.001
Exercise price					$ .058			$ 0.1400
Warrant term	1 year 6 months
Warrant [Member]
Exercise price		$ 0.06
Warrant term		3 years
Subsequent Event [Member]
Aggregate proceeds from subscription agreement			$ 3,000,000
Commissions - gross proceeds (percent)			7.00%
Warrant commission - amount of shares sold (percent)			8.00%
Price of securities paid by investors (percent)			110.00%
Subsequent Event [Member] | Exercise Price #1 [Member] | Warrant [Member]
Percent exercisable				50.00%
Exercise price				$ 0.05
Subsequent Event [Member] | Exercise Price #2 [Member] | Warrant [Member]
Percent exercisable				50.00%
Exercise price				$ 0.075
Subsequent Event [Member] | Debentures [Member]
Senior debenture offering amount				$ 3,000,000
Number of shares to purchase				8,000,000
Common shares, par value (in dollars per share)				$ 0.001
Interest rate				11.00%
Warrant term				5 years
Subsequent Event [Member] | Debentures [Member] | Eastern Sphere Ltd [Member]
Percent ownership pledged as collateral				49.00%
Subsequent Event [Member] | Debentures [Member] | Exercise Price #1 [Member]
Percent exercisable				50.00%
Exercise price				$ 0.05
Subsequent Event [Member] | Debentures [Member] | Exercise Price #2 [Member]
Percent exercisable				50.00%
Exercise price				$ 0.075